{
  "dataset_version": "0.6.0",
  "kinds": [
    {
      "description": "Limits what a drug maker may do to hold back 340B drugs from a pharmacy that works under contract with a covered entity, or to put conditions on sending them.",
      "kind": "contract-pharmacy",
      "label": "Contract pharmacy access"
    },
    {
      "description": "Limits what an insurer, a pharmacy benefit manager or another payer may do to a 340B covered entity or its pharmacy, such as paying less for a 340B drug or leaving the pharmacy out of a network.",
      "kind": "payer-nondiscrimination",
      "label": "Payer and PBM non-discrimination"
    },
    {
      "description": "Requires covered entities, or others, to report 340B figures to the state, or a state office to publish them.",
      "kind": "reporting",
      "label": "Reporting"
    },
    {
      "description": "Sets rules for 340B drugs in the state's Medicaid program, such as how they are billed or paid for.",
      "kind": "medicaid",
      "label": "Medicaid"
    },
    {
      "description": "Says how a covered entity is to use what it earns or saves through 340B.",
      "kind": "use-of-savings",
      "label": "Use of savings"
    },
    {
      "description": "Orders a study, a task force or a one-time report on 340B.",
      "kind": "study",
      "label": "Study"
    },
    {
      "description": "Names 340B and does something the kinds above do not cover.",
      "kind": "other",
      "label": "Other"
    }
  ],
  "laws": [
    {
      "act": "Act 1103 of 2021",
      "bill": "HB 1881",
      "binds": "Insurers, pharmacy benefit managers and other payers; drug manufacturers",
      "citation": "Ark. Code 23-92-601 to 23-92-606",
      "effective_date": "",
      "enforcement": "The act names no penalty. The Insurance Commissioner writes the rules.",
      "kinds": [
        "contract-pharmacy",
        "payer-nondiscrimination"
      ],
      "law_id": "ar-2021-hb1881",
      "limits": "Arkansas Medicaid, risk-based provider organizations and self-insured government plans are not third parties under the act.",
      "more_sha256": "ee0bcdd76613ef5d6c9d21467454316e4164ae9d140810146aee25f38930409e",
      "more_text": "sources/laws/ar/ar-2021-hb1881.more.txt",
      "more_url": "https://arkleg.state.ar.us/Bills/Detail?id=HB1881&ddBienniumSession=2021%2F2021R",
      "quote": "Prohibit a pharmacy from contracting or participating with an entity authorized to participate in 340B drug pricing by denying access to drugs that are manufactured by the pharmaceutical manufacturer",
      "retrieved": "2026-11-15",
      "session_year": "2021",
      "signed_date": "2021-05-03",
      "source_form": "pdf",
      "source_note": "The saved pages print no effective date.",
      "source_sha256": "b86147b7306dad196dcbb94a0ebcef51958438d03ca36e814a5460c3aae5604a",
      "source_text": "sources/laws/ar/ar-2021-hb1881.txt",
      "source_url": "https://arkleg.state.ar.us/Acts/FTPDocument?path=%2FACTS%2F2021R%2FPublic%2F&file=1103.pdf&ddBienniumSession=2021%2F2021R",
      "state": "AR",
      "summary": "Insurers, pharmacy benefit managers and other payers may not pay a pharmacy less, add separate terms or claim modifiers, or leave it out of a network on the ground that it takes part in 340B. Drug manufacturers may not deny drugs to a pharmacy that contracts with a 340B entity.",
      "title": "340B Drug Pricing Nondiscrimination Act"
    },
    {
      "act": "Laws 2016, ch. 122",
      "bill": "HB 2704",
      "binds": "340B covered entities; the state Medicaid agency (AHCCCS) and its contractors",
      "citation": "A.R.S. 36-2930.03",
      "effective_date": "",
      "enforcement": "",
      "kinds": [
        "medicaid",
        "study"
      ],
      "law_id": "az-2016-hb2704",
      "limits": "Starts on the later of January 1, 2017 or federal approval. Licensed hospitals and their outpatient facilities are outside the rule.",
      "more_sha256": "4d8793074d3f9623db805f1dfe5dc83b754b30ce55d75b965bcf2345500805c6",
      "more_text": "sources/laws/az/az-2016-hb2704.more.txt",
      "more_url": "https://www.azleg.gov/ars/36/02930-03.htm",
      "quote": "The administration and its contractors may not reimburse any contracted pharmacy for drugs dispensed as part of the 340B drug pricing program",
      "retrieved": "2026-11-15",
      "session_year": "2016",
      "signed_date": "2016-05-10",
      "source_form": "web page",
      "source_note": "",
      "source_sha256": "9e5a23209cc90bd7fa31b55327dfe905ba343bc9965c3ccc8ec5e84fdc66e588",
      "source_text": "sources/laws/az/az-2016-hb2704.txt",
      "source_url": "https://www.azleg.gov/legtext/52leg/2R/laws/0122.htm",
      "state": "AZ",
      "summary": "In Arizona Medicaid (AHCCCS), a 340B covered entity bills drugs at the lesser of its actual acquisition cost or the 340B ceiling price, plus a professional fee, and is paid on that basis. AHCCCS and its contractors may not pay contract pharmacies for drugs dispensed as part of 340B. AHCCCS reports on whether the rule could reach hospitals.",
      "title": ""
    },
    {
      "act": "Laws 2022, ch. 288",
      "bill": "SB 1176",
      "binds": "Health insurers; pharmacy benefit managers",
      "citation": "A.R.S. 20-3341 to 20-3343",
      "effective_date": "",
      "enforcement": "",
      "kinds": [
        "payer-nondiscrimination"
      ],
      "law_id": "az-2022-sb1176",
      "limits": "Applies to contracts issued, delivered or renewed on or after January 1, 2024. The state Medicaid agency (AHCCCS), its contractors and the AIDS drug assistance program are outside it.",
      "more_sha256": "7d621b2df882493b5f0a6a8015f0b1f76823edd84eae54aeaef4ce7bd7ea6a40",
      "more_text": "sources/laws/az/az-2022-sb1176.more.txt",
      "more_url": "https://www.azleg.gov/legtext/55leg/2R/laws/0288.htm",
      "quote": "Exclude a pharmacy from a third party's pharmacy network on the basis that the pharmacy dispenses a 340B drug",
      "retrieved": "2026-11-15",
      "session_year": "2022",
      "signed_date": "2022-06-13",
      "source_form": "web page",
      "source_note": "",
      "source_sha256": "d774f11a5e0218efbc7a92e68e00f0ef6c3b844ade2428b98e44be9ae3366afe",
      "source_text": "sources/laws/az/az-2022-sb1176.txt",
      "source_url": "https://www.azleg.gov/ars/20/03343.htm",
      "state": "AZ",
      "summary": "An insurer or pharmacy benefit manager that pays for 340B drugs may not pay a pharmacy less, add fees or clawbacks, or drop it from a network for dispensing them, and may not restrict how or through which pharmacies a 340B entity dispenses or delivers them.",
      "title": ""
    },
    {
      "act": "Stats. 2009, 4th Ex. Sess., ch. 5, sec. 40",
      "bill": "",
      "binds": "340B covered entities that bill Medi-Cal",
      "citation": "Cal. Welf. & Inst. Code 14105.46",
      "effective_date": "2009-07-28",
      "enforcement": "",
      "kinds": [
        "medicaid"
      ],
      "law_id": "ca-2009-wic-14105-46",
      "limits": "Applies to Medi-Cal, the state Medicaid program, only.",
      "more_sha256": "",
      "more_text": "",
      "more_url": "",
      "quote": "A covered entity shall dispense only 340B drugs to Medi-Cal beneficiaries",
      "retrieved": "2026-11-15",
      "session_year": "2009",
      "signed_date": "",
      "source_form": "web page",
      "source_note": "",
      "source_sha256": "93a4518b586a4401328e35dfb694c50136a9bedc4b18ecf1bfb078329b937cb8",
      "source_text": "sources/laws/ca/ca-2009-wic-14105-46.txt",
      "source_url": "https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?lawCode=WIC&sectionNum=14105.46.",
      "state": "CA",
      "summary": "A 340B covered entity dispenses only 340B drugs to Medi-Cal patients, bills Medi-Cal no more than its actual acquisition cost plus the set fee, and marks 340B drugs on its claims. Where it cannot buy a drug at the 340B price it may use another and keeps a record of that.",
      "title": ""
    },
    {
      "act": "Stats. 2023, ch. 414",
      "bill": "SB 786",
      "binds": "Pharmacy benefit managers",
      "citation": "Cal. Health & Safety Code 127470 and 127471",
      "effective_date": "",
      "enforcement": "",
      "kinds": [
        "payer-nondiscrimination"
      ],
      "law_id": "ca-2023-sb786",
      "limits": "Does not apply to Medi-Cal or Medicare themselves; it does apply to pharmacy benefit managers that contract with managed care plans serving their members. Carried out only so far as it is consistent with the federal 340B law.",
      "more_sha256": "",
      "more_text": "",
      "more_url": "",
      "quote": "that is registered with the 340B discount drug purchasing program to dispense covered drugs on behalf of the covered entity",
      "retrieved": "2026-11-15",
      "session_year": "2023",
      "signed_date": "2023-10-07",
      "source_form": "web page",
      "source_note": "The saved page prints no effective date.",
      "source_sha256": "00aa294d21501ccdba21bf02b9ce5cb1782c87345617f29ea34529cb60d59af4",
      "source_text": "sources/laws/ca/ca-2023-sb786.txt",
      "source_url": "https://leginfo.legislature.ca.gov/faces/billTextClient.xhtml?bill_id=202320240SB786",
      "state": "CA",
      "summary": "A pharmacy benefit manager may not set terms that treat a 340B covered entity, or a pharmacy it owns or contracts with, differently for covered drugs: lower or different payment, network exclusion, extra audits or steering patients away. It may not stop the entity from keeping the benefit of the discounted price.",
      "title": ""
    },
    {
      "act": "Initiative statute",
      "bill": "Proposition 34 (November 5, 2024 ballot)",
      "binds": "Entities that meet the act's test of a 'prescription drug price manipulator'",
      "citation": "Cal. Welf. & Inst. Code 14124.39 to 14124.52",
      "effective_date": "2024-12-18",
      "enforcement": "An entity that does not meet the 98 percent rule can lose licences, state and local grants and its California tax-exempt status.",
      "kinds": [
        "reporting",
        "use-of-savings"
      ],
      "law_id": "ca-2024-prop34",
      "limits": "Reaches only an entity that meets every part of the test, among them spending over $100,000,000 on purposes other than direct patient care in a ten-year period and being an owner and operator of highly dangerous multifamily housing. Effective December 18, 2024 and operative January 1, 2025.",
      "more_sha256": "fcfafe4a801ae57dfa820c23db292f6fd9bc58f98993bb94dafac0b28e948d95",
      "more_text": "sources/laws/ca/ca-2024-prop34.more.txt",
      "more_url": "https://vig.cdn.sos.ca.gov/2024/general/pdf/prop34-text-proposed-laws.pdf",
      "quote": "Public Health Service Act (Sec. 340B; 42 U.S.C. Sec. 256b",
      "retrieved": "2026-11-15",
      "session_year": "2024",
      "signed_date": "",
      "source_form": "web page",
      "source_note": "",
      "source_sha256": "72f6a0303c02f4175f66b0ecbbf7777c36bf0a554e94a4f945a39438aac49c85",
      "source_text": "sources/laws/ca/ca-2024-prop34.txt",
      "source_url": "https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?lawCode=WIC&sectionNum=14124.48.",
      "state": "CA",
      "summary": "An entity that meets the act's test of a 'prescription drug price manipulator' keeps its tax-exempt status and its pharmacy, health plan or clinic licences only if, in the prior year, it spent at least 98 percent of its California net revenue from the 340B program on direct patient care. It sends a yearly accounting to state agencies.",
      "title": "Protect Patients Now Act of 2024"
    },
    {
      "act": "Session Laws of Colorado 2022, ch. 312",
      "bill": "HB 22-1122",
      "binds": "Health carriers, pharmacy benefit managers and other third-party payers",
      "citation": "C.R.S. 10-16-1501 to 10-16-1506; 10-3-1104 (1)(tt)",
      "effective_date": "",
      "enforcement": "A breach is an unfair or deceptive insurance practice. The Commissioner of Insurance may adopt rules.",
      "kinds": [
        "payer-nondiscrimination"
      ],
      "law_id": "co-2022-hb22-1122",
      "limits": "The modifier rule does not apply to claims paid by Medicaid. Takes effect after the ninety days allowed for a referendum petition.",
      "more_sha256": "",
      "more_text": "",
      "more_url": "",
      "quote": "ASSESS ANY FEE, CHARGE BACK, OR OTHER ADJUSTMENT AGAINST THE 340B COVERED ENTITY OR CONTRACT PHARMACY ON THE BASIS THAT THE 340B COVERED ENTITY OR CONTRACT PHARMACY PARTICIPATES IN THE 340B PROGRAM",
      "retrieved": "2026-11-15",
      "session_year": "2022",
      "signed_date": "2022-06-02",
      "source_form": "pdf",
      "source_note": "The saved page prints no calendar date for the start.",
      "source_sha256": "dc0c12790461932b0f604eb57c2e63b8f73329ddbb9110ebaa289aea0ba1b032",
      "source_text": "sources/laws/co/co-2022-hb22-1122.txt",
      "source_url": "https://leg.colorado.gov/laws/session-laws/HB22-1122/312/download",
      "state": "CO",
      "summary": "A payer may not pay a 340B covered entity or its contract pharmacy less than similar pharmacies outside the program, charge fees or chargebacks for taking part, restrict network access, add patient charges, or require a 340B modifier on a claim.",
      "title": "Colorado 340B Prescription Drug Program Anti-Discrimination Act"
    },
    {
      "act": "Session Laws of Colorado 2025, ch. 313",
      "bill": "SB 25-071",
      "binds": "Drug manufacturers, third-party logistics providers and repackagers; hospitals that are 340B covered entities",
      "citation": "C.R.S. 6-29-101 to 6-29-105; 25-3-134; 6-1-105 (1)(oooo)",
      "effective_date": "",
      "enforcement": "A breach is a deceptive trade practice the Attorney General may pursue for civil penalties; each package of drugs counts once. The pharmacy board may discipline a licensee.",
      "kinds": [
        "contract-pharmacy",
        "reporting",
        "use-of-savings"
      ],
      "law_id": "co-2025-sb25-071",
      "limits": "Data that federal law requires is allowed. Limited distribution required by 21 U.S.C. 355-1 is allowed. The savings limits and the report apply to reporting hospitals, not clinics. Takes effect after the ninety days allowed for a referendum petition.",
      "more_sha256": "",
      "more_text": "",
      "more_url": "",
      "quote": "SHALL NOT, DIRECTLY OR INDIRECTLY , DENY , RESTRICT, PROHIBIT, DISCRIMINATE AGAINST, OR OTHERWISE LIMIT THE ACQUISITION OF A 340B DRUG BY , OR DELIVERY OF A 340B DRUG TO , A 340B COVERED ENTITY",
      "retrieved": "2026-11-15",
      "session_year": "2025",
      "signed_date": "2025-05-30",
      "source_form": "pdf",
      "source_note": "The saved page prints no calendar date for the start.",
      "source_sha256": "2da3ab9862cb23ad4bcf15e7c1872ebb466ba11ea824402be69f890bbab6486c",
      "source_text": "sources/laws/co/co-2025-sb25-071.txt",
      "source_url": "https://leg.colorado.gov/laws/session-laws/SB25-071/313/download",
      "state": "CO",
      "summary": "Manufacturers, their logistics providers and repackagers may not deny, restrict or limit 340B drugs reaching a covered entity, its contract pharmacy or another authorized location, and may not require claims or other data as a condition. Hospital covered entities report their 340B savings, costs and charity care each year, and may not spend savings on a listed set of items such as lobbying, advertising and board travel.",
      "title": "Colorado 340B Contract Pharmacy Protection Act"
    },
    {
      "act": "Public Act 23-171",
      "bill": "HB 6669",
      "binds": "Pharmacy benefit managers; the Commissioner of Social Services",
      "citation": "Public Act 23-171, sections 15 and 16",
      "effective_date": "2023-10-01",
      "enforcement": "A contract term that breaks the rule is void. The act names no fine.",
      "kinds": [
        "payer-nondiscrimination",
        "study"
      ],
      "law_id": "ct-2023-hb6669",
      "limits": "The contract rule starts January 1, 2024. The working group's report was due once, by January 31, 2024.",
      "more_sha256": "",
      "more_text": "",
      "more_url": "",
      "quote": "Any provision that excludes a 340B covered entity from pharmacy benefit manager networks based on the 340B covered entity's participation in the federal 340B Drug Pricing Program",
      "retrieved": "2026-11-15",
      "session_year": "2023",
      "signed_date": "2023-06-27",
      "source_form": "pdf",
      "source_note": "",
      "source_sha256": "95fc16321324e01224253d662c390d8fa2e399061c13bc59adbe14ddeb7526d8",
      "source_text": "sources/laws/ct/ct-2023-hb6669.txt",
      "source_url": "https://www.cga.ct.gov/2023/ACT/PA/PDF/2023PA-00171-R00HB-06669-PA.PDF",
      "state": "CT",
      "summary": "A contract between a pharmacy benefit manager and a 340B covered entity, its contract pharmacies included, may not set a lower payment rate, add fees, interfere with a patient's choice or keep the entity out of a network on the ground that it takes part in 340B. The Commissioner of Social Services runs a working group on 340B and health centers and reports on it.",
      "title": ""
    },
    {
      "act": "84 Del. Laws, ch. 408",
      "bill": "HS 1 for HB 383",
      "binds": "Pharmacy benefits managers; purchasers of pharmacy benefits",
      "citation": "18 Del. C. 3374A",
      "effective_date": "",
      "enforcement": "A breach is an unfair practice in the business of insurance, enforced by the Insurance Commissioner.",
      "kinds": [
        "payer-nondiscrimination"
      ],
      "law_id": "de-2024-hb383",
      "limits": "Applies to contracts entered into, amended, extended or renewed after September 19, 2024; a term that breaks the rule is void.",
      "more_sha256": "e8de2280c40a5ff2d5cffe5dd1e31072113c88456fd40e473b06e4bed535bc96",
      "more_text": "sources/laws/de/de-2024-hb383.more.txt",
      "more_url": "https://legis.delaware.gov/SessionLaws/Chapter?id=42039",
      "quote": "A pharmacy benefits manager or purchaser may not discriminate, either directly or indirectly, against a covered entity or the covered entity's contracted pharmacy on the basis of its participation in the 340B program",
      "retrieved": "2026-11-15",
      "session_year": "2024",
      "signed_date": "2024-09-19",
      "source_form": "web page",
      "source_note": "The act's title also names Title 24 and manufacturers; the saved pages show the insurance section only.",
      "source_sha256": "c304c31aba74759cd57869e6b1e1f9b9c6a76fab31eb9f4548489ea75d59f52d",
      "source_text": "sources/laws/de/de-2024-hb383.txt",
      "source_url": "https://delcode.delaware.gov/title18/c033a/sc07/index.html",
      "state": "DE",
      "summary": "A pharmacy benefits manager or purchaser may not treat a 340B covered entity or its contract pharmacy less well for taking part in 340B: no payment below the national average drug acquisition cost, no added fees, clawbacks, audits or claim re-submissions, and no interference with a patient's choice.",
      "title": ""
    },
    {
      "act": "Act 143, Session Laws of Hawaii 2025",
      "bill": "HB 712",
      "binds": "Drug manufacturers; 340B covered entities; the state hospital trade association",
      "citation": "HRS chapter 481N",
      "effective_date": "2025-07-01",
      "enforcement": "The Attorney General may sue; the fine is $500 to $2,500 for each violation, and each day counts once.",
      "kinds": [
        "contract-pharmacy",
        "reporting"
      ],
      "law_id": "hi-2025-hb712",
      "limits": "Does not apply where the U.S. Department of Health and Human Services prohibits the delivery. A covered entity's own suit can seek an injunction, fees and costs only.",
      "more_sha256": "55676bac26c5fb38597480b4f8282da40f78b2c93929a6efab93eefdffa71f82",
      "more_text": "sources/laws/hi/hi-2025-hb712.more.txt",
      "more_url": "https://data.capitol.hawaii.gov/sessions/sessionlaws/Years/SLH2025/SLH2025_Act143.pdf",
      "quote": "each 340B covered entity shall report to the hospital trade association",
      "retrieved": "2026-11-15",
      "session_year": "2025",
      "signed_date": "2025-05-30",
      "source_form": "web page",
      "source_note": "",
      "source_sha256": "e14cf1dac42ff6012a4a3348327f39e456205e69c7e1381dc3bd44a9238dd63b",
      "source_text": "sources/laws/hi/hi-2025-hb712.txt",
      "source_url": "https://data.capitol.hawaii.gov/hrscurrent/Vol11_Ch0476-0490/HRS0481N/HRS_0481N-0006.htm",
      "state": "HI",
      "summary": "A manufacturer may not deny, restrict or prohibit delivery of 340B drugs to a pharmacy under contract with a covered entity; it may ask for claims data, up to three years back, to check for diversion and duplicate discounts. From July 1, 2026 each covered entity reports contract pharmacy figures to the hospital trade association, which posts a combined public report from October 1, 2027.",
      "title": ""
    },
    {
      "act": "2023 Iowa Acts, ch. 43",
      "bill": "HF 423",
      "binds": "Group health plans, health carriers, third-party administrators and pharmacy benefits managers",
      "citation": "Iowa Code chapter 510D; 507B.4(3)(u)",
      "effective_date": "",
      "enforcement": "A breach is an unfair or deceptive insurance practice; the Insurance Commissioner may order penalties after notice and a hearing.",
      "kinds": [
        "payer-nondiscrimination"
      ],
      "law_id": "ia-2023-hf423",
      "limits": "Does not apply to work done under a contract with the state Medicaid agency or a Medicaid managed care organization. A claim modifier that marks a 340B drug, or prevents a duplicate rebate, is allowed.",
      "more_sha256": "4222821d8cde60d8769f683fc14b4e832c6d0ddbb858034d5832a11457304b9e",
      "more_text": "sources/laws/ia/ia-2023-hf423.more.txt",
      "more_url": "https://www.legis.iowa.gov/docs/code/2025/510D.6.pdf",
      "quote": "RELATING TO CONTRACT PHARMACIES AND COVERED ENTITIES THAT PARTICIPATE IN THE 340B DRUG PROGRAM",
      "retrieved": "2026-11-15",
      "session_year": "2023",
      "signed_date": "",
      "source_form": "pdf",
      "source_note": "The saved pages print no signing or effective date.",
      "source_sha256": "bc0a080f34a0f9a71b3a5086cc5f3e539c50a928e74949e97ab0bfb17ebd10e0",
      "source_text": "sources/laws/ia/ia-2023-hf423.txt",
      "source_url": "https://www.legis.iowa.gov/docs/publications/LGE/90/HF423.pdf",
      "state": "IA",
      "summary": "Health plans, carriers, administrators and pharmacy benefits managers may not pay a 340B covered entity or contract pharmacy less than a similar pharmacy outside the program, or set different fees, chargebacks, network rules, audit terms or disclosure demands on the ground of 340B status. They may not restrict a patient's choice of a 340B pharmacy.",
      "title": ""
    },
    {
      "act": "2025 Session Laws, ch. 246",
      "bill": "HB 136",
      "binds": "340B covered entities; the State Controller",
      "citation": "Idaho Code 41-351",
      "effective_date": "2025-07-01",
      "enforcement": "",
      "kinds": [
        "reporting"
      ],
      "law_id": "id-2025-hb136",
      "limits": "An entity's own report is confidential. The Attorney General may use it for Medicaid fraud work and for compliance with the federal program.",
      "more_sha256": "f0af7437cb7f5521242eeac040e948fc2a643a1d7040dafcf9f8377b5f64171c",
      "more_text": "sources/laws/id/id-2025-hb136.more.txt",
      "more_url": "https://legislature.idaho.gov/sessioninfo/2025/legislation/H0136/",
      "quote": "Before April 1 of each year, a 340B covered entity shall report the following information to the state department of health and welfare, the state controller's office, and the attorney general",
      "retrieved": "2026-11-15",
      "session_year": "2025",
      "signed_date": "2025-04-01",
      "source_form": "web page",
      "source_note": "",
      "source_sha256": "4f0b3dcf8d8e2f41b4b259d10553c91f4a47f551b0f5625a52ad1b646f3ce877",
      "source_text": "sources/laws/id/id-2025-hb136.txt",
      "source_url": "https://legislature.idaho.gov/statutesrules/idstat/Title41/T41CH3/SECT41-351/",
      "state": "ID",
      "summary": "Before April 1 each year a 340B covered entity reports to the Department of Health and Welfare, the State Controller and the Attorney General: what it paid for 340B drugs, what it was paid for them, what it paid contract pharmacies, claim counts and how it uses the savings, split by commercial, Medicaid and Medicare. The Controller publishes a combined report each November.",
      "title": ""
    },
    {
      "act": "Public Act 102-0778",
      "bill": "HB 4595",
      "binds": "Pharmacy benefit managers and third-party payers; Medicaid managed care organizations",
      "citation": "215 ILCS 5/513b1 and 5/424; 305 ILCS 5/5-36",
      "effective_date": "2022-07-01",
      "enforcement": "A breach by a pharmacy benefit manager is an unfair or deceptive act in the business of insurance.",
      "kinds": [
        "payer-nondiscrimination",
        "medicaid"
      ],
      "law_id": "il-2022-hb4595",
      "limits": "A term that breaks the rule is void in contracts entered into, amended or renewed after July 1, 2022.",
      "more_sha256": "11e8e5569d640169128d56e83a776c29725a29093037f5ca03c54f0b55f470e3",
      "more_text": "sources/laws/il/il-2022-hb4595.more.txt",
      "more_url": "https://ilga.gov/ftp/legislation/102/BillStatus/HTML/10200HB4595.html",
      "quote": "A provision that violates subsection (f) in a contract between a pharmacy benefit manager or a third-party payer and a 340B entity that is entered into, amended, or renewed after July 1, 2022 shall be void and unenforceable",
      "retrieved": "2026-11-15",
      "session_year": "2022",
      "signed_date": "2022-05-13",
      "source_form": "web page",
      "source_note": "",
      "source_sha256": "47967a178d737f974946faf717c97287bbb72606249e03cfba0dad336269f6ae",
      "source_text": "sources/laws/il/il-2022-hb4595.txt",
      "source_url": "https://my.ilga.gov/ftp/Public%20Acts/102/102-0778.htm",
      "state": "IL",
      "summary": "A contract between a pharmacy benefit manager or third-party payer and a 340B entity or 340B pharmacy may not pay it less, add fees or chargebacks, limit a patient's choice, keep it out of a network or otherwise treat it differently for taking part in 340B. A separate subsection sets the same rule for Medicaid managed care organizations.",
      "title": ""
    },
    {
      "act": "Public Act 104-0758",
      "bill": "HB 2371",
      "binds": "Drug manufacturers and any other person; 340B covered entities; the Department of Healthcare and Family Services",
      "citation": "",
      "effective_date": "2026-08-07",
      "enforcement": "The Attorney General enforces. A court may order an injunction, damages to the covered entity and a civil penalty of up to $1,000 for each violation.",
      "kinds": [
        "contract-pharmacy",
        "reporting",
        "medicaid",
        "study"
      ],
      "law_id": "il-2026-hb2371",
      "limits": "Hospitals with fewer than 100 licensed beds, Critical Access Hospitals, Safety-Net Hospitals and 340B grantees need not report until January 1, 2029. The Medicaid report is due by January 1, 2028. 340B dispensing is limited to patients who had an outpatient service in the last 18 months.",
      "more_sha256": "",
      "more_text": "",
      "more_url": "",
      "quote": "No person, including a pharmaceutical manufacturer, may deny, restrict, prohibit, condition, or otherwise interfere with, either directly or indirectly, the acquisition of a 340B drug by, or delivery of a 340B drug to, a 340B covered entity or a 340B contract pharmacy authorized to receive 340B drugs on behalf of the 340B covered entity unless the receipt is prohibited by federal law",
      "retrieved": "2026-11-15",
      "session_year": "2026",
      "signed_date": "",
      "source_form": "web page",
      "source_note": "The saved page prints no code number for the act.",
      "source_sha256": "71af7819337eeb159320295ef1ce2afbf245ff57f7af4b8a00a622e802686a3f",
      "source_text": "sources/laws/il/il-2026-hb2371.txt",
      "source_url": "https://www.ilga.gov/Legislation/PublicActs/View/104-0758",
      "state": "IL",
      "summary": "No person, a drug manufacturer included, may deny, restrict or place conditions on 340B drugs reaching a covered entity or its contract pharmacy, limit the number or place of contract pharmacies, or demand pricing or claims data. Covered entities file a yearly 340B report with the General Assembly and keep a policy against duplicate discounts; the state Medicaid agency reports once on 340B units and savings.",
      "title": "Patient Access to Pharmacy Protection Act"
    },
    {
      "act": "Public Act 104-0769",
      "bill": "HB 4327",
      "binds": "The Department of Insurance; 340B covered entities and drug manufacturers in Illinois",
      "citation": "",
      "effective_date": "2026-08-07",
      "enforcement": "An answer more than 30 days late draws a fine of $500 a day, or $100 a day for small hospitals, Critical Access Hospitals, Safety-Net Hospitals and 340B grantees.",
      "kinds": [
        "reporting",
        "study"
      ],
      "law_id": "il-2026-hb4327",
      "limits": "The act is repealed on July 1, 2032. It does not regulate pricing, reimbursement or participation in the federal program.",
      "more_sha256": "",
      "more_text": "",
      "more_url": "",
      "quote": "the Department of Insurance shall conduct a comprehensive study of how 340B covered entities and pharmaceutical manufacturers within Illinois participate in the 340B Drug Discount Program",
      "retrieved": "2026-11-15",
      "session_year": "2026",
      "signed_date": "",
      "source_form": "web page",
      "source_note": "The saved page prints no code number for the act.",
      "source_sha256": "1f9b0a8eeb4c5de72fee7768f93ba57223a61b54ae2278c6b687ad3e83b7df38",
      "source_text": "sources/laws/il/il-2026-hb4327.txt",
      "source_url": "https://ilga.gov/Legislation/PublicActs/View/104-0769",
      "state": "IL",
      "summary": "The Department of Insurance studies how 340B covered entities and drug manufacturers in Illinois take part in the program and reports to the General Assembly and the Governor by July 1, 2028. Covered entities and manufacturers answer its requests on acquisition cost, payments received, contract pharmacies and the use of savings.",
      "title": "340B Transparency, Reporting, and Accountability Act"
    },
    {
      "act": "House Enrolled Act 1405 (2021), section 23",
      "bill": "HB 1405",
      "binds": "Pharmacy benefit managers; Medicaid managed care organizations",
      "citation": "IC 27-1-24.5-19.5",
      "effective_date": "2021-07-01",
      "enforcement": "A breach by a pharmacy benefit manager is an unfair or deceptive act in the business of insurance.",
      "kinds": [
        "payer-nondiscrimination",
        "medicaid"
      ],
      "law_id": "in-2021-hb1405",
      "limits": "A term that breaks the rule is void in contracts made, amended or renewed after June 30, 2021. Does not apply to fee-for-service Medicaid.",
      "more_sha256": "",
      "more_text": "",
      "more_url": "",
      "quote": "The following provisions may not be contained in a contract between a pharmacy benefit manager and a 340B covered entity",
      "retrieved": "2026-11-15",
      "session_year": "2021",
      "signed_date": "",
      "source_form": "pdf",
      "source_note": "",
      "source_sha256": "59466904a12ef2e99c9c0641593836207620cc2886aca55d371f7c56e0ae129e",
      "source_text": "sources/laws/in/in-2021-hb1405.txt",
      "source_url": "https://iga.in.gov/pdf-documents/122/2021/house/bills/HB1405/HB1405.05.ENRS.pdf",
      "state": "IN",
      "summary": "A contract between a pharmacy benefit manager and a 340B covered entity, its contract pharmacies included, may not carry a payment rate that reduces the 340B benefit, added fees, exclusion from a network for taking part in 340B, or terms that interfere with a patient's choice. The section applies to Medicaid managed care organizations too.",
      "title": ""
    },
    {
      "act": "Senate Enrolled Act 118 (2025)",
      "bill": "SB 118",
      "binds": "340B covered entities with an Indiana service address; the state Department of Health",
      "citation": "IC 16-40-6",
      "effective_date": "2025-07-01",
      "enforcement": "A late report draws a fine of $1,000 for each day past due.",
      "kinds": [
        "reporting"
      ],
      "law_id": "in-2025-sb118",
      "limits": "Covers entities described in 42 U.S.C. 256b(a)(4)(L) to (O) and their offsite outpatient facilities. An entity's own report is confidential.",
      "more_sha256": "",
      "more_text": "",
      "more_url": "",
      "quote": "Before April 1 of each year, a 340B covered entity shall report the following information and transactions to the state department",
      "retrieved": "2026-11-15",
      "session_year": "2025",
      "signed_date": "",
      "source_form": "pdf",
      "source_note": "",
      "source_sha256": "400a34e50e81c6d6dc4cdd43355f98faff31d2a3e62c3ccf2bd54bb9bc8a9b11",
      "source_text": "sources/laws/in/in-2025-sb118.txt",
      "source_url": "https://iga.in.gov/pdf-documents/124/2025/senate/bills/SB0118/SB0118.05.ENRH.pdf",
      "state": "IN",
      "summary": "Before April 1 each year a 340B covered entity with an Indiana service address reports to the state Department of Health: its 340B acquisition costs, payments received, payments to contract pharmacies, how it uses 340B savings, charity care included, and its financial assistance policy. The department publishes a combined report each year.",
      "title": ""
    },
    {
      "act": "2020 Ky. Acts ch. 70",
      "bill": "SB 50",
      "binds": "The Department for Medicaid Services; the state pharmacy benefit manager for Medicaid managed care",
      "citation": "KRS 205.510 to 205.560 (new sections)",
      "effective_date": "",
      "enforcement": "",
      "kinds": [
        "payer-nondiscrimination",
        "medicaid"
      ],
      "law_id": "ky-2020-sb50",
      "limits": "Covers Medicaid managed care only. The act names the program by its section of federal law, not as 340B. Took effect on approval under an emergency clause.",
      "more_sha256": "46c986694435f7cc4de7aa7ad49fc42502c3627138c024fca937d230270bfaa3",
      "more_text": "sources/laws/ky/ky-2020-sb50.more.txt",
      "more_url": "https://apps.legislature.ky.gov/record/20rs/sb50.html",
      "quote": "Reimbursement methodologies established by administrative regulations shall not discriminate against pharmacies owned or contracted by a health care facility that is registered as a covered entity pursuant to 42 U.S.C. sec. 256b, to the extent allowable by the Centers for Medicare and Medicaid Services",
      "retrieved": "2026-11-15",
      "session_year": "2020",
      "signed_date": "2020-03-27",
      "source_form": "pdf",
      "source_note": "",
      "source_sha256": "9127e0748c387dc4aedd56b0bb9b2c99f2995d90853bed41bebc021128153e89",
      "source_text": "sources/laws/ky/ky-2020-sb50.txt",
      "source_url": "https://apps.legislature.ky.gov/law/acts/20RS/documents/0070.pdf",
      "state": "KY",
      "summary": "Kentucky Medicaid's pharmacy payment rules may not discriminate against pharmacies owned by, or under contract with, a facility registered as a covered entity under 42 U.S.C. 256b, so far as the federal Medicaid agency allows. The state's single pharmacy benefit manager for Medicaid managed care processes claims in line with any contract between such an entity and a managed care plan.",
      "title": ""
    },
    {
      "act": "Act 358 of 2023",
      "bill": "HB 548",
      "binds": "Health insurers, pharmacy benefit managers and other third-party payers; drug manufacturers and distributors",
      "citation": "La. R.S. 40:2881 through 2886",
      "effective_date": "2023-08-01",
      "enforcement": "A breach is a violation of the Unfair Trade Practices and Consumer Protection Law. There is no private right of action.",
      "kinds": [
        "contract-pharmacy",
        "payer-nondiscrimination"
      ],
      "law_id": "la-2023-hb548",
      "limits": "Does not apply to Louisiana Medicaid as payer. Limited distribution required by 21 U.S.C. 355-1 is allowed.",
      "more_sha256": "747ac49889917a49aff7bff32bc565537423adc4adcce1106629fdaf6f06b487",
      "more_text": "sources/laws/la/la-2023-hb548.more.txt",
      "more_url": "https://legis.la.gov/legis/BillInfo.aspx?&i=244536",
      "quote": "Reimburse a 340B entity for 340B drugs at a rate lower than that paid for the same drug to entities that are not 340B entities or lower reimbursement for a claim on the basis that the claim is for a 340B drug",
      "retrieved": "2026-11-15",
      "session_year": "2023",
      "signed_date": "",
      "source_form": "pdf",
      "source_note": "",
      "source_sha256": "ce52e767685b16a774822d41a4d6f945ea080f8479b1d07ffd0a05c39a613b9c",
      "source_text": "sources/laws/la/la-2023-hb548.txt",
      "source_url": "https://legis.la.gov/legis/ViewDocument.aspx?d=1332515",
      "state": "LA",
      "summary": "Insurers, pharmacy benefit managers and other payers may not pay a 340B entity less for 340B drugs, set different terms or fees, require a 340B marker on a claim or keep it out of a network. A manufacturer or distributor may not deny, restrict or interfere with a 340B drug reaching a pharmacy under contract with a 340B entity.",
      "title": "Defending Affordable Prescription Drug Costs Act"
    },
    {
      "act": "Chapter 365, Acts of 2022",
      "bill": "HB 1274",
      "binds": "Pharmacy benefits managers",
      "citation": "Md. Code, Insurance 15-1611.2",
      "effective_date": "2022-10-01",
      "enforcement": "",
      "kinds": [
        "payer-nondiscrimination"
      ],
      "law_id": "md-2022-hb1274",
      "limits": "",
      "more_sha256": "00ecf866dfb9014099fda70a25910ae7d97bbaad7762489c778f666a5f348652",
      "more_text": "sources/laws/md/md-2022-hb1274.more.txt",
      "more_url": "https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/hb1274?ys=2022RS",
      "quote": "offer lower reimbursement for a prescription drug purchased under the 340B Program than the reimbursement it offers for the same prescription drug if it is not purchased under the 340B Program",
      "retrieved": "2026-11-15",
      "session_year": "2022",
      "signed_date": "2022-05-16",
      "source_form": "web page",
      "source_note": "",
      "source_sha256": "f92fa5d0c563c6b7453b5604e0e76548bfb40a2cc503aa6fa234319406dabb91",
      "source_text": "sources/laws/md/md-2022-hb1274.txt",
      "source_url": "https://mgaleg.maryland.gov/mgawebsite/Laws/StatuteText?article=gin&section=15-1611.2&enactments=false",
      "state": "MD",
      "summary": "A pharmacy benefits manager may not pay less for a drug bought under 340B than for the same drug bought outside it, refuse to cover or contract with a 340B pharmacy, set different fees or contract terms, change a patient's copay, or base formulary decisions on 340B status.",
      "title": ""
    },
    {
      "act": "Chapter 962, Acts of 2024",
      "bill": "HB 1056",
      "binds": "340B manufacturers; the Prescription Drug Affordability Board",
      "citation": "Md. Code, Health Occupations 12-6C-09.1; Commercial Law 13-301",
      "effective_date": "2024-07-01",
      "enforcement": "A breach is an unfair, abusive or deceptive trade practice with a civil fine of $5,000 for each violation; each package of drugs counts once. There is no private right of action.",
      "kinds": [
        "contract-pharmacy",
        "study"
      ],
      "law_id": "md-2024-hb1056",
      "limits": "Does not apply where the U.S. Department of Health and Human Services prohibits the delivery. Limited distribution required by 21 U.S.C. 355-1 is allowed.",
      "more_sha256": "11a09702f67f65cd6a2e2e71b3aac717da6ed3f9a3e8633c52618b34f4672b2b",
      "more_text": "sources/laws/md/md-2024-hb1056.more.txt",
      "more_url": "https://mgaleg.maryland.gov/2024RS/chapters_noln/Ch_962_hb1056T.pdf",
      "quote": "a 340B manufacturer may not directly or indirectly deny, restrict, prohibit, discriminate against, or otherwise limit the acquisition of a 340B drug by, or delivery of a 340B drug to, a pharmacy that is under contract with or otherwise authorized by a covered entity to receive 340B drugs on behalf of the covered entity",
      "retrieved": "2026-11-15",
      "session_year": "2024",
      "signed_date": "2024-05-16",
      "source_form": "web page",
      "source_note": "",
      "source_sha256": "65c64f0df5a001b51fcb8ed42e41915f9af4ccc0d9be03a00820e06c24712390",
      "source_text": "sources/laws/md/md-2024-hb1056.txt",
      "source_url": "https://mgaleg.maryland.gov/mgawebsite/Laws/StatuteText?article=gho&section=12-6C-09.1&enactments=false",
      "state": "MD",
      "summary": "A 340B manufacturer may not deny, restrict or otherwise limit a 340B drug reaching a pharmacy under contract with, or authorized by, a covered entity. The Prescription Drug Affordability Board studies the 340B program in Maryland and reports by July 1, 2026.",
      "title": ""
    },
    {
      "act": "P.L. 2023, ch. 276",
      "bill": "LD 1395",
      "binds": "Hospitals in the 340B program; the Maine Health Data Organization",
      "citation": "22 M.R.S. 1728",
      "effective_date": "",
      "enforcement": "",
      "kinds": [
        "reporting"
      ],
      "law_id": "me-2023-ld1395",
      "limits": "Reporting began January 1, 2024. A second report, on acquisition costs and payments, was added in 2025 and is due from July 1, 2026.",
      "more_sha256": "98696aa335ca204c06c2b90c808bac49a028c311acb5929e4761237f1adbda55",
      "more_text": "sources/laws/me/me-2023-ld1395.more.txt",
      "more_url": "https://lldc.mainelegislature.org/Open/Laws/2023/2023_PL_c276.pdf",
      "quote": "each hospital participating in the federal drug pricing program under Section 340B of the federal Public Health Service Act, 42 United States Code, Section 256b",
      "retrieved": "2026-11-15",
      "session_year": "2023",
      "signed_date": "",
      "source_form": "web page",
      "source_note": "The saved pages print no signing or effective date.",
      "source_sha256": "b5966880ca3061bff8fba84237039d0410c33d57edf85dd4476bb65c6ad8baea",
      "source_text": "sources/laws/me/me-2023-ld1395.txt",
      "source_url": "https://www.mainelegislature.org/legis/Statutes/22/title22sec1728.html",
      "state": "ME",
      "summary": "Each Maine hospital in the 340B program files a yearly report with the Maine Health Data Organization on how it uses 340B savings for its community, its estimated savings set against its total drug spending, and how it oversees the program. The organization posts the reports and a summary.",
      "title": ""
    },
    {
      "act": "P.L. 2025, ch. 388, Part P",
      "bill": "",
      "binds": "Drug manufacturers; health insurers, pharmacy benefits managers and other third-party payers",
      "citation": "24-A M.R.S. 7753 and 7754",
      "effective_date": "",
      "enforcement": "",
      "kinds": [
        "contract-pharmacy",
        "payer-nondiscrimination"
      ],
      "law_id": "me-2025-pl388-part-p",
      "limits": "A payer may still use preferred pharmacies where the choice does not rest on 340B status. A claim marker is allowed where federal Medicare or Medicaid authorities, or the state for MaineCare, require one.",
      "more_sha256": "fcd820e864cc4af5be797a755fa72b769ce948f66ddc284fa1d9a00e526589aa",
      "more_text": "sources/laws/me/me-2025-pl388-part-p.more.txt",
      "more_url": "https://legislature.maine.gov/legis/statutes/24-a/title24-Asec7753.html",
      "quote": "With respect to reimbursement of a 340B entity for 340B drugs",
      "retrieved": "2026-11-15",
      "session_year": "2025",
      "signed_date": "",
      "source_form": "web page",
      "source_note": "The saved pages are two sections of the chapter; they print no bill number and no signing or effective date.",
      "source_sha256": "9e843df9ee2bb61159936559b8f641aef8ed8c495bfd661695e426ffd5530908",
      "source_text": "sources/laws/me/me-2025-pl388-part-p.txt",
      "source_url": "https://legislature.maine.gov/legis/statutes/24-a/title24-Asec7754.html",
      "state": "ME",
      "summary": "A manufacturer may not deny, restrict or interfere with a 340B drug reaching a 340B contract pharmacy, and may not require a 340B entity to send claims or utilization data. Insurers, pharmacy benefits managers and other payers may not pay a 340B entity less for 340B drugs, set different terms or fees, require a 340B marker on a claim or keep it out of a network.",
      "title": ""
    },
    {
      "act": "2022 PA 11",
      "bill": "HB 4348",
      "binds": "Pharmacy benefit managers; insurance carriers",
      "citation": "2022 PA 11, section 19",
      "effective_date": "2024-01-01",
      "enforcement": "",
      "kinds": [
        "payer-nondiscrimination"
      ],
      "law_id": "mi-2022-hb4348",
      "limits": "One subsection of an act that licenses pharmacy benefit managers.",
      "more_sha256": "3fe549c3a77ac17d0a19dfd426e0cd19b42500cf8a94cbbe07784f5a8bea64b5",
      "more_text": "sources/laws/mi/mi-2022-hb4348.more.txt",
      "more_url": "https://www.legislature.mi.gov/Bills/Bill?ObjectName=2021-HB-4348",
      "quote": "A pharmacy benefit manager or carrier shall not prohibit a 340B Program entity or a pharmacy that has a license in good standing in this state under contract with a 340B Program entity from participating in the pharmacy benefit manager's or carrier's provider network solely because it is a 340B Program entity or a pharmacy under contract with a 340B Program entity",
      "retrieved": "2026-11-15",
      "session_year": "2022",
      "signed_date": "2022-02-23",
      "source_form": "web page",
      "source_note": "",
      "source_sha256": "960e5e40b06bcbfcd58913a53c68f546afabaa20f9c920f6945ff63e3272aa95",
      "source_text": "sources/laws/mi/mi-2022-hb4348.txt",
      "source_url": "https://www.legislature.mi.gov/documents/2021-2022/publicact/htm/2022-PA-0011.htm",
      "state": "MI",
      "summary": "A pharmacy benefit manager or carrier may not keep a 340B entity, or a licensed pharmacy under contract with one, out of its network solely for taking part in 340B, and may not pay them differently from similar pharmacies.",
      "title": "Pharmacy Benefit Manager Licensure and Regulation Act"
    },
    {
      "act": "2022 PA 12",
      "bill": "HB 4351",
      "binds": "Carriers and third party administrators that act as pharmacy benefit managers",
      "citation": "1984 PA 218, sections 26 and 27",
      "effective_date": "2022-02-23",
      "enforcement": "The director may order a civil fine of up to $10,000 for each violation of a cease and desist order, or suspend or revoke a licence.",
      "kinds": [
        "payer-nondiscrimination"
      ],
      "law_id": "mi-2022-hb4351",
      "limits": "A modifier is allowed where the law requires one to prevent a duplicate rebate, and on claims paid by Medicaid.",
      "more_sha256": "c47974fc2470a0893c8888b3ed8a8e1139714f6d566c55c78617c8d87d4e4780",
      "more_text": "sources/laws/mi/mi-2022-hb4351.more.txt",
      "more_url": "https://www.legislature.mi.gov/Bills/Bill?ObjectName=2021-HB-4351",
      "quote": "A carrier or third party administrator that is a pharmacy benefit manager shall not reimburse a 340B Program entity or a pharmacy under contract with a 340B Program entity differently than other similarly situated pharmacies",
      "retrieved": "2026-11-15",
      "session_year": "2022",
      "signed_date": "2022-02-23",
      "source_form": "web page",
      "source_note": "",
      "source_sha256": "fcee179df4ca1bd54eea7e885fd01d2c34cea1187767d7924ae8c5a1c9efe937",
      "source_text": "sources/laws/mi/mi-2022-hb4351.txt",
      "source_url": "https://www.legislature.mi.gov/documents/2021-2022/publicact/htm/2022-PA-0012.htm",
      "state": "MI",
      "summary": "A carrier or third party administrator that is a pharmacy benefit manager may not keep a 340B entity, or a licensed pharmacy under contract with one, out of its network solely for that reason, pay them differently from similar pharmacies, or require a 340B modifier on a claim.",
      "title": ""
    },
    {
      "act": "2022 PA 13",
      "bill": "HB 4352",
      "binds": "Pharmacies and pharmacists",
      "citation": "1978 PA 368, section 17757b",
      "effective_date": "2022-02-23",
      "enforcement": "",
      "kinds": [
        "payer-nondiscrimination"
      ],
      "law_id": "mi-2022-hb4352",
      "limits": "Tied to House Bill 4351 of the same session, which is listed.",
      "more_sha256": "6c8f53e035819a5f874fb0e8bdf42849d493226332e89cb4e2712d3e04912b3b",
      "more_text": "sources/laws/mi/mi-2022-hb4352.more.txt",
      "more_url": "https://www.legislature.mi.gov/Bills/Bill?ObjectName=2021-HB-4352",
      "quote": "A pharmacy or pharmacist engaged in the business of selling drugs shall not enter into a contract with a pharmacy benefit manager that violates section 26 of the third party administrator act, 1984 PA 218, MCL 550.926, or that prevents or interferes with in any manner a patient's choice to receive an eligible prescription drug from a 340b entity or a pharmacy when dispensing a 340b drug",
      "retrieved": "2026-11-15",
      "session_year": "2022",
      "signed_date": "2022-02-23",
      "source_form": "web page",
      "source_note": "",
      "source_sha256": "7c06f041d84c4a49e381edd2326e8d1239866bf2d45272912ea20003ed8b171c",
      "source_text": "sources/laws/mi/mi-2022-hb4352.txt",
      "source_url": "https://www.legislature.mi.gov/documents/2021-2022/publicact/htm/2022-PA-0013.htm",
      "state": "MI",
      "summary": "A pharmacy or pharmacist may not sign a contract with a pharmacy benefit manager that breaks section 26 of the third party administrator act, or that interferes with a patient's choice to get a drug from a 340B entity or a pharmacy that dispenses 340B drugs.",
      "title": ""
    },
    {
      "act": "Laws 2019, ch. 39",
      "bill": "SF 278",
      "binds": "Pharmacy benefit managers; health carriers",
      "citation": "Minn. Stat. 62W.07",
      "effective_date": "2019-07-01",
      "enforcement": "",
      "kinds": [
        "payer-nondiscrimination"
      ],
      "law_id": "mn-2019-sf278",
      "limits": "For a pharmacy benefit manager that works for a Medicaid managed care or county-based purchasing plan, the rule holds only where all 340B-eligible claims can be identified at the point of sale, and that manager may pay a lower rate for drugs bought through 340B.",
      "more_sha256": "3fcccf930b307b06d649a25a6a3bc7dd4992ae0641faa07f7aac29bec2b1a00b",
      "more_text": "sources/laws/mn/mn-2019-sf278.more.txt",
      "more_url": "https://www.revisor.mn.gov/bills/bill.php?b=Senate&f=SF278&ssn=0&y=2019",
      "quote": "A pharmacy benefit manager or health carrier must not reimburse an entity or a pharmacy under contract with such an entity participating in the federal 340B Drug Pricing Program differently than other similarly situated pharmacies",
      "retrieved": "2026-11-15",
      "session_year": "2019",
      "signed_date": "2019-05-17",
      "source_form": "web page",
      "source_note": "",
      "source_sha256": "fd6dd8ab0b167244bd577876867c1b79f859663bdcea44d9c777421795f4fa72",
      "source_text": "sources/laws/mn/mn-2019-sf278.txt",
      "source_url": "https://www.revisor.mn.gov/statutes/cite/62W.07",
      "state": "MN",
      "summary": "A pharmacy benefit manager or health carrier may not keep a 340B entity, or a pharmacy under contract with one, out of its network, and may not pay them differently from similar pharmacies.",
      "title": ""
    },
    {
      "act": "Laws 2024, ch. 121, art. 4, sec. 3",
      "bill": "HF 4757",
      "binds": "Drug manufacturers",
      "citation": "Minn. Stat. 62J.96",
      "effective_date": "",
      "enforcement": "",
      "kinds": [
        "contract-pharmacy"
      ],
      "law_id": "mn-2024-hf4757",
      "limits": "Does not apply where the 340B program itself prohibits the delivery. The section expires July 1, 2027.",
      "more_sha256": "a9c8c8c029c8df7b05c70affaaeca2dee5c7f32eaeb4528887240994751b2e2b",
      "more_text": "sources/laws/mn/mn-2024-hf4757.more.txt",
      "more_url": "https://www.revisor.mn.gov/laws/2024/0/Session+Law/Chapter/121/",
      "quote": "A manufacturer must not directly or indirectly restrict, prohibit, or otherwise interfere with the delivery of a covered outpatient drug to a pharmacy that is under contract with a 340B covered entity",
      "retrieved": "2026-11-15",
      "session_year": "2024",
      "signed_date": "2024-05-24",
      "source_form": "web page",
      "source_note": "The saved pages print no effective date.",
      "source_sha256": "b7acf274d94a35fdbb56451d22bf6bf7adbec9e00d5de320da9352b24725ed23",
      "source_text": "sources/laws/mn/mn-2024-hf4757.txt",
      "source_url": "https://www.revisor.mn.gov/statutes/cite/62J.96",
      "state": "MN",
      "summary": "A manufacturer may not restrict, prohibit or otherwise interfere with the delivery of a covered outpatient drug to a pharmacy under contract with a 340B covered entity.",
      "title": ""
    },
    {
      "act": "Laws 2024, ch. 127, art. 59, sec. 2",
      "bill": "HF 5247",
      "binds": "340B covered entities with a Minnesota service address; the Commissioner of Health",
      "citation": "Minn. Stat. 62J.461",
      "effective_date": "",
      "enforcement": "A covered entity whose data is late can be fined up to $500 for each day.",
      "kinds": [
        "reporting"
      ],
      "law_id": "mn-2024-hf5247",
      "limits": "The data sent to the commissioner is not public. The commissioner may grant more time or an exemption for good cause. Amended in 2025.",
      "more_sha256": "f5ffa2fe1d2e0e478ba945a870dccc58203c45d26fa30a574b40a00c009e5cee",
      "more_text": "sources/laws/mn/mn-2024-hf5247.more.txt",
      "more_url": "https://www.revisor.mn.gov/bills/bill.php?b=House&f=HF5247&ssn=0&y=2024",
      "quote": "Each 340B covered entity shall report to the commissioner by April 1 of each year the following information for transactions conducted by the 340B covered entity or on its behalf, and related to its participation in the federal 340B program for the previous calendar year",
      "retrieved": "2026-11-15",
      "session_year": "2024",
      "signed_date": "2024-05-24",
      "source_form": "web page",
      "source_note": "",
      "source_sha256": "73fbb6e366aca2cd2b18b6b835216c9f0deaa42900d0d7b9f1fb0978c599e829",
      "source_text": "sources/laws/mn/mn-2024-hf5247.txt",
      "source_url": "https://www.revisor.mn.gov/statutes/cite/62J.461",
      "state": "MN",
      "summary": "Each 340B covered entity with a Minnesota address keeps a registration with the Commissioner of Health and reports by April 1 each year what it paid for 340B drugs, what it was paid for them by payer type, units dispensed, and what it paid contract pharmacies and program managers. The commissioner reports combined results to the legislature each November 15.",
      "title": ""
    },
    {
      "act": "L. 2024 S.B. 751",
      "bill": "SB 751",
      "binds": "Drug manufacturers and third-party logistics providers, with their agents and affiliates",
      "citation": "RSMo 376.414",
      "effective_date": "2024-08-28",
      "enforcement": "A breach is an unlawful practice under section 407.020; each package of drugs counts once. The Board of Pharmacy may investigate and discipline its licensees.",
      "kinds": [
        "contract-pharmacy"
      ],
      "law_id": "mo-2024-sb751",
      "limits": "Does not apply where the U.S. Department of Health and Human Services prohibits the delivery. Limited distribution required by 21 U.S.C. 355-1 is allowed. Wholesale drug distributors are not agents or affiliates.",
      "more_sha256": "392b0dae9ef2225f01b91a24da34bfbd7984324df286826c7ebf3fa19c20152a",
      "more_text": "sources/laws/mo/mo-2024-sb751.more.txt",
      "more_url": "https://www.senate.mo.gov/24info/pdf-bill/tat/SB751.pdf",
      "quote": "A pharmaceutical manufacturer, third-party logistics provider, or an agent or affiliate of such pharmaceutical manufacturer or third-party logistics provider shall not deny, restrict, or prohibit, either directly or indirectly, the acquisition of a 340B drug by, or delivery of a 340B drug to, a pharmacy that is under contract with, or otherwise authorized by, a covered entity",
      "retrieved": "2026-11-15",
      "session_year": "2024",
      "signed_date": "",
      "source_form": "web page",
      "source_note": "",
      "source_sha256": "f448f2c6c801e6fb414d3b9ea354c45964281b2517666806b32071ff2e99a433",
      "source_text": "sources/laws/mo/mo-2024-sb751.txt",
      "source_url": "https://revisor.mo.gov/main/OneSection.aspx?section=376.414",
      "state": "MO",
      "summary": "A drug manufacturer or third-party logistics provider, or an agent or affiliate of either, may not deny, restrict or prohibit a 340B drug reaching a pharmacy under contract with, or authorized by, a covered entity.",
      "title": ""
    },
    {
      "act": "L. 2026 H.B. 2372 merged with S.B. 878",
      "bill": "SB 878 (merged with HB 2372)",
      "binds": "Health carriers and pharmacy benefits managers, with their agents and affiliates",
      "citation": "RSMo 376.417",
      "effective_date": "2026-08-28",
      "enforcement": "The Department of Commerce and Insurance writes the rules and imposes a civil penalty of up to $5,000 for each violation for each day.",
      "kinds": [
        "payer-nondiscrimination"
      ],
      "law_id": "mo-2026-sb878",
      "limits": "",
      "more_sha256": "baa350bb298f198395af197b22b0184d2148e19d62c33daa3217cc0c4775c525",
      "more_text": "sources/laws/mo/mo-2026-sb878.more.txt",
      "more_url": "https://www.senate.mo.gov/26info/pdf-bill/tat/SB878.pdf",
      "quote": "Covered entity\", any entity described in subparagraphs (A) to (K) of subsection (a)(4) of Section 340B of the Public Health Service Act, 42 U.S.C. Section 256b, including any pharmacy with which such entity has contracted to dispense 340B drugs on behalf of the entity",
      "retrieved": "2026-11-15",
      "session_year": "2026",
      "signed_date": "",
      "source_form": "web page",
      "source_note": "",
      "source_sha256": "217f0bdf1082b679b87208cc04dc9e0e6c9be98452d7813ec79f28ae762f5100",
      "source_text": "sources/laws/mo/mo-2026-sb878.txt",
      "source_url": "https://revisor.mo.gov/main/OneSection.aspx?section=376.417",
      "state": "MO",
      "summary": "A health carrier or pharmacy benefits manager may not discriminate against a 340B covered entity or its contract pharmacy: it may not pay it less than similar pharmacies, set different terms or fees, require it to mark 340B drugs, refuse to cover drugs bought through 340B, or have it redo claims after payment.",
      "title": ""
    },
    {
      "act": "Laws 2024, ch. 319",
      "bill": "HB 728",
      "binds": "Health insurers, pharmacy benefit managers and other third-party payers; drug manufacturers and distributors",
      "citation": "Laws 2024, ch. 319, sections 1 to 6; Miss. Code 75-24-5",
      "effective_date": "2024-07-01",
      "enforcement": "A breach is a violation of the Consumer Protection Act each time it happens. There is no private right of action.",
      "kinds": [
        "contract-pharmacy",
        "payer-nondiscrimination"
      ],
      "law_id": "ms-2024-hb728",
      "limits": "Does not apply to Mississippi Medicaid as payer.",
      "more_sha256": "fe7cea6b724ac007d533a16de6434d306ae197ebc43ca25d4e0bfa0a1359ed59",
      "more_text": "sources/laws/ms/ms-2024-hb728.more.txt",
      "more_url": "https://billstatus.ls.state.ms.us/2024/pdf/history/HB/HB0728.xml",
      "quote": "A manufacturer or distributor shall not deny, restrict, prohibit, or otherwise interfere with, either directly or indirectly, the acquisition of a 340B drug by, or delivery of a 340B drug to, a pharmacy that is under contract with a 340B entity",
      "retrieved": "2026-11-15",
      "session_year": "2024",
      "signed_date": "",
      "source_form": "pdf",
      "source_note": "The saved pages print the day and month of approval without the year.",
      "source_sha256": "655e9690c93c5e5441b9926206d7374736ef981867d2440443bd95315cca56a3",
      "source_text": "sources/laws/ms/ms-2024-hb728.txt",
      "source_url": "https://billstatus.ls.state.ms.us/documents/2024/pdf/HB/0700-0799/HB0728SG.pdf",
      "state": "MS",
      "summary": "Insurers, pharmacy benefit managers and other payers may not pay a 340B entity less for 340B drugs, set terms, fees or claim modifiers that others do not face, or keep it out of a network. A manufacturer or distributor may not deny, restrict or interfere with a 340B drug reaching a pharmacy under contract with a 340B entity.",
      "title": "Defending Affordable Prescription Drug Costs Act"
    },
    {
      "act": "Ch. 215, L. 2019",
      "bill": "",
      "binds": "Health insurers, plan sponsors outside ERISA and pharmacy benefit managers",
      "citation": "MCA 33-22-180",
      "effective_date": "",
      "enforcement": "The Insurance Commissioner fines up to $5,000 for each violation, to a limit of $100,000 a year for each entity.",
      "kinds": [
        "payer-nondiscrimination"
      ],
      "law_id": "mt-2019-ch215",
      "limits": "The section names the program by its section of federal law, not as 340B.",
      "more_sha256": "",
      "more_text": "",
      "more_url": "",
      "quote": "A patient eligible to receive drugs under an agreement covered by 42 U.S.C. 256b may not be discriminated against through conditions imposed on a federally certified health entity or its contract pharmacy through which the patient is eligible to receive drugs",
      "retrieved": "2026-11-15",
      "session_year": "2019",
      "signed_date": "",
      "source_form": "web page",
      "source_note": "The statute page prints the chapter of the act, not its bill number, and no signing or effective date.",
      "source_sha256": "b639239721300f1b6739b14bf7a3e10251c02986c25d054d221d88fe7633a8e4",
      "source_text": "sources/laws/mt/mt-2019-ch215.txt",
      "source_url": "https://mca.legmt.gov/bills/mca/title_0330/chapter_0220/part_0010/section_0800/0330-0220-0010-0800.html",
      "state": "MT",
      "summary": "A contract with a federally certified health entity may not pay it or its contract pharmacy below a rate set from a state survey, or add fees aimed only at it. A patient eligible for drugs under 42 U.S.C. 256b may not be discriminated against through conditions placed on that entity or its contract pharmacy.",
      "title": ""
    },
    {
      "act": "Ch. 501, L. 2021",
      "bill": "",
      "binds": "Pharmacy benefit managers; health carriers",
      "citation": "MCA 33-2-2410",
      "effective_date": "",
      "enforcement": "",
      "kinds": [
        "payer-nondiscrimination"
      ],
      "law_id": "mt-2021-ch501",
      "limits": "The modifier rule does not cover claims paid by Medicaid, and that subsection ends June 1, 2029.",
      "more_sha256": "",
      "more_text": "",
      "more_url": "",
      "quote": "the drug is a 340B drug unless the claim is for payment",
      "retrieved": "2026-11-15",
      "session_year": "2021",
      "signed_date": "",
      "source_form": "web page",
      "source_note": "The statute page prints the chapter of the act, not its bill number, and no signing or effective date.",
      "source_sha256": "5fd7177a4553ff2d859f54ef844c6429a0affe0a52e88ec3c1f6578ca3e67527",
      "source_text": "sources/laws/mt/mt-2021-ch501.txt",
      "source_url": "https://mca.legmt.gov/bills/mca/title_0330/chapter_0020/part_0240/section_0100/0330-0020-0240-0100.html",
      "state": "MT",
      "summary": "A pharmacy benefit manager or health carrier may not keep a federally certified health entity, or a pharmacy under contract with one, out of its network, pay them differently from similar pharmacies, require a 340B modifier on a claim, or add a restriction or charge for patients who choose them.",
      "title": ""
    },
    {
      "act": "S.L. 2021-161",
      "bill": "S 257",
      "binds": "Pharmacy benefits managers",
      "citation": "G.S. 58-56A-1, 58-56A-50 and 58-51-37",
      "effective_date": "2021-10-01",
      "enforcement": "A contract term that conflicts is unenforceable.",
      "kinds": [
        "payer-nondiscrimination"
      ],
      "law_id": "nc-2021-s257",
      "limits": "Applies to contracts entered into, renewed or amended on or after October 1, 2021.",
      "more_sha256": "401107a9fbf0aaf14b2a7377ae18d8f37dad5d7423ba584ed35a40b982937628",
      "more_text": "sources/laws/nc/nc-2021-s257.more.txt",
      "more_url": "https://www.ncleg.gov/EnactedLegislation/Statutes/HTML/BySection/Chapter_58/GS_58-56A-50.html",
      "quote": "Restrict access to a pharmacy network or adjust 340B drug reimbursement rates based on whether a pharmacy dispenses drugs under the 340B drug discount program",
      "retrieved": "2026-11-15",
      "session_year": "2021",
      "signed_date": "2021-09-20",
      "source_form": "web page",
      "source_note": "",
      "source_sha256": "31563997c0a97191e0b939c11c7c60c5c208365fcdb8c2feb296f6c4c9bd6a0a",
      "source_text": "sources/laws/nc/nc-2021-s257.txt",
      "source_url": "https://www.ncleg.gov/EnactedLegislation/SessionLaws/HTML/2021-2022/SL2021-161.html",
      "state": "NC",
      "summary": "A contract between a pharmacy benefits manager and a 340B covered entity's pharmacy, or a 340B contract pharmacy, may not restrict network access or change payment on the ground of 340B dispensing, or add fees or chargebacks on the ground of 340B status. A pharmacy benefits manager may not interfere with an enrollee's choice of an in-network 340B pharmacy.",
      "title": ""
    },
    {
      "act": "S.L. 2025-69",
      "bill": "S 479",
      "binds": "Pharmacy benefits managers; Medicaid prepaid health plans",
      "citation": "G.S. 58-51-37; S.L. 2021-180, section 9D.19A",
      "effective_date": "2025-10-01",
      "enforcement": "A plan term that conflicts is void.",
      "kinds": [
        "payer-nondiscrimination",
        "medicaid"
      ],
      "law_id": "nc-2025-s479",
      "limits": "The pharmacy-of-choice part applies to insurance contracts entered into or amended on or after October 1, 2025.",
      "more_sha256": "",
      "more_text": "",
      "more_url": "",
      "quote": "This section shall apply to pharmacy benefits managers with respect to 340B covered entities and 340B contract pharmacies, as defined in G.S. 58-56A-1",
      "retrieved": "2026-11-15",
      "session_year": "2025",
      "signed_date": "2025-07-09",
      "source_form": "web page",
      "source_note": "",
      "source_sha256": "f7654cc497419a0c804d28c119ed74e2e82a2e52640c6609eab29cf9ed552825",
      "source_text": "sources/laws/nc/nc-2025-s479.txt",
      "source_url": "https://ncleg.gov/EnactedLegislation/SessionLaws/HTML/2025-2026/SL2025-69.html",
      "state": "NC",
      "summary": "The state's pharmacy-of-choice section now applies to pharmacy benefits managers with respect to 340B covered entities and 340B contract pharmacies. In Medicaid managed care, claims for drugs bought through 340B are paid under the Medicaid State Plan.",
      "title": ""
    },
    {
      "act": "",
      "bill": "HB 1492",
      "binds": "Pharmacy benefits managers",
      "citation": "N.D.C.C. 19-02.1-16.5",
      "effective_date": "",
      "enforcement": "Each violation is a class B misdemeanor.",
      "kinds": [
        "payer-nondiscrimination"
      ],
      "law_id": "nd-2021-hb1492",
      "limits": "Passed as an emergency measure.",
      "more_sha256": "f3b4d0227523320642786a4a66ccb9e7653cc59b2459f49e57e61648c1a833a3",
      "more_text": "sources/laws/nd/nd-2021-hb1492.more.txt",
      "more_url": "https://ndlegis.gov/assembly/67-2021/regular/bill-actions/ba1492.html",
      "quote": "A pharmacy benefits manager may not discriminate against or interfere with a covered entity participating under section 340B of the federal Public Health Service Act [42 U.S.C. 201 et seq",
      "retrieved": "2026-11-15",
      "session_year": "2021",
      "signed_date": "",
      "source_form": "pdf",
      "source_note": "The saved pages print the day and month of signing without the year, and no effective date.",
      "source_sha256": "11777ce7c38f6cf6540a3224f9e0c4886e5baf4225234467a980725acc18b8ae",
      "source_text": "sources/laws/nd/nd-2021-hb1492.txt",
      "source_url": "https://ndlegis.gov/assembly/67-2021/regular/documents/21-0892-05000.pdf",
      "state": "ND",
      "summary": "A pharmacy benefits manager may not discriminate against or interfere with a 340B covered entity or a pharmacy under contract with it: it may not refuse to contract with that pharmacy, lower the payment for a drug bought under 340B, or charge the pharmacy claims-network fees. Contract and claim information between the entity and the pharmacy is confidential.",
      "title": ""
    },
    {
      "act": "",
      "bill": "HB 1473",
      "binds": "Drug manufacturers, their agents and affiliates, and third-party logistics providers",
      "citation": "N.D.C.C. 43-15.3-08",
      "effective_date": "",
      "enforcement": "A violation is a class B misdemeanor.",
      "kinds": [
        "contract-pharmacy"
      ],
      "law_id": "nd-2025-hb1473",
      "limits": "Limited distribution required by 21 U.S.C. 355-1 is allowed. Data that federal law requires is allowed.",
      "more_sha256": "f37b25ef8f03b14ed2a13c116ad75d3ce0823d2e53a2260add5339efe135ce2b",
      "more_text": "sources/laws/nd/nd-2025-hb1473.more.txt",
      "more_url": "https://ndlegis.gov/assembly/69-2025/regular/bill-actions/ba1473.html",
      "quote": "means a drug purchased under reduced pricing under section 340B",
      "retrieved": "2026-11-15",
      "session_year": "2025",
      "signed_date": "",
      "source_form": "pdf",
      "source_note": "The saved pages print the day and month of signing without the year, and no effective date.",
      "source_sha256": "4d11890e5b4f8888e67deaee422f619e4432f2af9a7cab946181de2c5ec31a56",
      "source_text": "sources/laws/nd/nd-2025-hb1473.txt",
      "source_url": "https://ndlegis.gov/assembly/69-2025/regular/documents/25-1047-02000.pdf",
      "state": "ND",
      "summary": "A manufacturer, its agent or affiliate, or a third-party logistics provider may not deny or interfere with a contract pharmacy getting or dispensing 340B drugs for a covered entity, require claims or utilization data as a condition, or offer a rebate in place of a discount at the time of sale.",
      "title": ""
    },
    {
      "act": "Laws 2022, LB 767, section 9",
      "bill": "LB 767",
      "binds": "Pharmacy benefit managers",
      "citation": "Neb. Rev. Stat. 44-4609",
      "effective_date": "2023-01-01",
      "enforcement": "The Director of Insurance enforces the act and may set a penalty of up to $1,000 for each entity for each violation.",
      "kinds": [
        "payer-nondiscrimination"
      ],
      "law_id": "ne-2022-lb767",
      "limits": "Operative January 1, 2023, for contracts and plans issued, renewed or amended on or after that date.",
      "more_sha256": "83150d75232e0fae074a39b88289c203e428ec11e762d912fc71842ff3119bf8",
      "more_text": "sources/laws/ne/ne-2022-lb767.more.txt",
      "more_url": "https://www.nebraskalegislature.gov/FloorDocs/107/PDF/Final/LB767.pdf",
      "quote": "A pharmacy benefit manager that reimburses a 340B entity or a 340B contract pharmacy for a drug that is subject to an agreement under 42 U.S.C. 256b shall not reimburse the 340B entity or the 340B contract pharmacy",
      "retrieved": "2026-11-15",
      "session_year": "2022",
      "signed_date": "",
      "source_form": "web page",
      "source_note": "",
      "source_sha256": "350c6fc5e0af18404c676c8242d4226ed8a1a35967fe06a583f40930fcfc187a",
      "source_text": "sources/laws/ne/ne-2022-lb767.txt",
      "source_url": "https://nebraskalegislature.gov/laws/statutes.php?statute=44-4609",
      "state": "NE",
      "summary": "A pharmacy benefit manager may not pay a 340B entity or 340B contract pharmacy less for a drug than it pays similar pharmacies outside the program, charge fees or chargebacks for taking part, or interfere with a patient's choice to use them.",
      "title": "Pharmacy Benefit Manager Licensure and Regulation Act"
    },
    {
      "act": "Laws 2025, LB 168",
      "bill": "LB 168",
      "binds": "Drug manufacturers, their agents and affiliates, and third-party logistics providers",
      "citation": "Laws 2025, LB 168, sections 1 to 5",
      "effective_date": "",
      "enforcement": "The Attorney General or a county attorney may sue for an injunction.",
      "kinds": [
        "contract-pharmacy"
      ],
      "law_id": "ne-2025-lb168",
      "limits": "Data that federal law requires is allowed. Took effect on approval under an emergency clause.",
      "more_sha256": "d7f87b7738d51d4bee8e43268132d51c6ecadc53a6bd24fcacf5ba4ca5540b80",
      "more_text": "sources/laws/ne/ne-2025-lb168.more.txt",
      "more_url": "https://governor.nebraska.gov/node/9568",
      "quote": "Any manufacturer, agent or affiliate of such manufacturer, or third-party logistics provider of such manufacturer's drugs shall not, either directly or indirectly, deny, restrict, or prohibit the acquisition of any 340B drug by or delivery of any 340B drug to any location authorized by any 340B entity to receive such 340B drug",
      "retrieved": "2026-11-15",
      "session_year": "2025",
      "signed_date": "2025-04-09",
      "source_form": "pdf",
      "source_note": "",
      "source_sha256": "74aa77e9c6b6861421eef255a4ce030667e7577e61ccb92d0f6ee33de73c9d9a",
      "source_text": "sources/laws/ne/ne-2025-lb168.txt",
      "source_url": "https://nebraskalegislature.gov/FloorDocs/109/PDF/Slip/LB168.pdf",
      "state": "NE",
      "summary": "A manufacturer, its agent or affiliate, or a third-party logistics provider may not deny, restrict or prohibit a 340B drug reaching any location a 340B entity authorizes, and may not require claim, utilization or other data as a condition.",
      "title": "340B Contract Pharmacy Protection Act"
    },
    {
      "act": "Laws 2024, 171:1",
      "bill": "",
      "binds": "Health insurers, pharmacy benefit managers and other third-party payers",
      "citation": "RSA 415:15-a",
      "effective_date": "2024-09-01",
      "enforcement": "",
      "kinds": [
        "payer-nondiscrimination"
      ],
      "law_id": "nh-2024-ch171",
      "limits": "A contract pharmacy is covered so far as it dispenses 340B drugs to the covered entity's patients.",
      "more_sha256": "",
      "more_text": "",
      "more_url": "",
      "quote": "a health insurance issuer, pharmacy benefit manager, other third-party payer, or its agent, shall not impose any terms or conditions, including, but not limited to, restrictions or requirements regarding participation in standard or preferred pharmacy networks or the imposition of a lower reimbursement amount for 340B covered drugs, on a covered entity or its contract pharmacy that differ from such terms or conditions that apply to any other entity",
      "retrieved": "2026-11-15",
      "session_year": "2024",
      "signed_date": "",
      "source_form": "web page",
      "source_note": "The statute page prints the chapter of the act, not its bill number.",
      "source_sha256": "40f2755842942b5f52e3eee535e2374fde953217836ef561b82cc6cadefda73e",
      "source_text": "sources/laws/nh/nh-2024-ch171.txt",
      "source_url": "https://gc.nh.gov/rsa/html/XXXVII/415/415-15-a.htm",
      "state": "NH",
      "summary": "An insurer, pharmacy benefit manager or other payer may not set terms for a 340B covered entity or its contract pharmacy, such as network limits or lower payment, that differ from the terms for others on the ground that it takes part in 340B.",
      "title": ""
    },
    {
      "act": "Laws 2023, ch. 206",
      "bill": "SB 51",
      "binds": "Pharmacy benefits managers and other third parties that pay for drugs",
      "citation": "New Mexico Insurance Code (new section)",
      "effective_date": "",
      "enforcement": "",
      "kinds": [
        "payer-nondiscrimination"
      ],
      "law_id": "nm-2023-sb51",
      "limits": "",
      "more_sha256": "97f7bf83ec3ec05ea54be0bdf1e8197399c5ee113770898375be37bee2d8fdcc",
      "more_text": "sources/laws/nm/nm-2023-sb51.more.txt",
      "more_url": "https://www.nmlegis.gov/Legislation/Legislation?chamber=S&legType=B&legNo=51&year=23",
      "quote": "A pharmacy benefits manager or a third party shall not discriminate against a covered entity on the basis of its participation in the 340B program by",
      "retrieved": "2026-11-15",
      "session_year": "2023",
      "signed_date": "",
      "source_form": "pdf",
      "source_note": "The saved pages print the day and month of signing without the year, and no effective date.",
      "source_sha256": "ac7064bf975334d067f80f9cc924a631e1f08347304fe258c75a970a530b9b4f",
      "source_text": "sources/laws/nm/nm-2023-sb51.txt",
      "source_url": "https://www.nmlegis.gov/Sessions/23%20Regular/final/SB0051.pdf",
      "state": "NM",
      "summary": "A pharmacy benefits manager or third party may not discriminate against a covered entity for taking part in 340B: it may not pay it less for a 340B drug than similar pharmacies, charge fees or chargebacks others do not pay, interfere with a person's choice to get 340B drugs from it, or set different terms such as extra audits or claim resubmission.",
      "title": ""
    },
    {
      "act": "Laws 2025, ch. 91",
      "bill": "HB 78",
      "binds": "Drug manufacturers, their agents and affiliates",
      "citation": "",
      "effective_date": "2026-01-01",
      "enforcement": "",
      "kinds": [
        "contract-pharmacy"
      ],
      "law_id": "nm-2025-hb78",
      "limits": "Covers federally qualified health centers and look-alikes only. Does not apply where the U.S. Department of Health and Human Services prohibits the delivery.",
      "more_sha256": "6392874e6abbc5b227da8f708adf4cd7d3bd37e59fb675be3d6b42285451cc0e",
      "more_text": "sources/laws/nm/nm-2025-hb78.more.txt",
      "more_url": "https://www.nmlegis.gov/Legislation/Legislation?chamber=H&legType=B&legNo=78&year=25",
      "quote": "deny, restrict, prohibit or interfere with the acquisition of a 340B drug",
      "retrieved": "2026-11-15",
      "session_year": "2025",
      "signed_date": "",
      "source_form": "pdf",
      "source_note": "",
      "source_sha256": "2882c3d14b078557d87de374de5d49cd50b74d2e994615a96c5806f9e336141b",
      "source_text": "sources/laws/nm/nm-2025-hb78.txt",
      "source_url": "https://nmlegis.gov/Sessions/25%20Regular/final/HB0078.PDF",
      "state": "NM",
      "summary": "A manufacturer, its agent or an affiliate may not deny, restrict or interfere with a 340B drug reaching a pharmacy under contract with a federally qualified health center or look-alike, and may not require claims or utilization data as a condition.",
      "title": ""
    },
    {
      "act": "Statutes of Nevada 2023, ch. 390",
      "bill": "AB 434",
      "binds": "Pharmacy benefit managers; health carriers, government self-insurance plans included; the state HIV drug program",
      "citation": "NRS 687B.805; new sections in NRS chapters 683A and 439",
      "effective_date": "2024-01-01",
      "enforcement": "",
      "kinds": [
        "payer-nondiscrimination",
        "other"
      ],
      "law_id": "nv-2023-ab434",
      "limits": "Does not apply to a pharmacy benefit manager when it manages Medicaid drug benefits under a state contract. Medicaid agencies and managed care organizations may still act to prevent duplicate discounts.",
      "more_sha256": "ea240241a8c0d08101ef1ff251060037af5e6bf5ff77c55a282f0a6bf116e3cb",
      "more_text": "sources/laws/nv/nv-2023-ab434.more.txt",
      "more_url": "https://www.leg.state.nv.us/Division/Legal/LawLibrary/Statutes/82nd2023/Stats202320.html",
      "quote": "Discriminate against a covered entity, a contract pharmacy or a 340B drug in the amount of reimbursement for any item or service or the procedures for obtaining such reimbursement",
      "retrieved": "2026-11-15",
      "session_year": "2023",
      "signed_date": "2023-06-12",
      "source_form": "web page",
      "source_note": "",
      "source_sha256": "822dbb94e76f7196756b255594917beac2fea2eea7586139058aac1ae77f6048",
      "source_text": "sources/laws/nv/nv-2023-ab434.txt",
      "source_url": "https://www.leg.state.nv.us/nrs/nrs-687b.html",
      "state": "NV",
      "summary": "A pharmacy benefit manager or health carrier may not discriminate against a covered entity, a contract pharmacy or a 340B drug in what it pays or how payment is obtained, charge fees or clawbacks, keep them out of a network, or set different cost sharing for 340B drugs. The state HIV drug program may not interfere with 340B purchasing.",
      "title": ""
    },
    {
      "act": "Senate Bill 263, 133rd General Assembly",
      "bill": "SB 263",
      "binds": "Health plan issuers and their third-party administrators; Medicaid managed care organizations",
      "citation": "R.C. 3902.71 and 5167.123",
      "effective_date": "2021-04-12",
      "enforcement": "A contract term that breaks the rule is unenforceable and gives way to the rate paid to other providers.",
      "kinds": [
        "payer-nondiscrimination",
        "medicaid"
      ],
      "law_id": "oh-2020-sb263",
      "limits": "The Medicaid managed care section is shown as amended by House Bill 96 in 2025.",
      "more_sha256": "35b0f169f3b994c6c42eb714c1ccb617c419b4b18baf69879eae39fa2d68a16d",
      "more_text": "sources/laws/oh/oh-2020-sb263.more.txt",
      "more_url": "https://codes.ohio.gov/ohio-revised-code/section-5167.123",
      "quote": "No health plan issuer or third-party administrator making payments pursuant to a health benefit plan shall discriminate against a 340B covered entity in a manner that prevents or interferes with an enrollee's choice to receive a prescription drug from a 340B covered entity or its contracted pharmacies",
      "retrieved": "2026-11-15",
      "session_year": "2020",
      "signed_date": "",
      "source_form": "web page",
      "source_note": "",
      "source_sha256": "02a07318266eee209bef1b4c43d2f21d2a398a717b6c3a1646d15e70b9c87787",
      "source_text": "sources/laws/oh/oh-2020-sb263.txt",
      "source_url": "https://codes.ohio.gov/ohio-revised-code/section-3902.71",
      "state": "OH",
      "summary": "A contract between a health plan issuer and a 340B covered entity may not pay less for a drug than the national average drug acquisition cost, pay a lower dispensing fee, or carry a fee that other providers do not pay. An issuer may not interfere with an enrollee's choice of a 340B covered entity or its contract pharmacies. A second section sets like rules for Medicaid managed care organizations and 340B grantees.",
      "title": ""
    },
    {
      "act": "House Bill 96, 136th General Assembly",
      "bill": "HB 96",
      "binds": "340B covered entities; the Ohio Department of Health",
      "citation": "R.C. 3701.88",
      "effective_date": "2025-09-30",
      "enforcement": "",
      "kinds": [
        "reporting"
      ],
      "law_id": "oh-2025-hb96",
      "limits": "The first report is due by July 1, 2026, and one is due each July 1 after that.",
      "more_sha256": "",
      "more_text": "",
      "more_url": "",
      "quote": "Not later than July 1, 2026, and not later than the first day of July in each year thereafter, each 340B covered entity shall submit a report to the department of health",
      "retrieved": "2026-11-15",
      "session_year": "2025",
      "signed_date": "",
      "source_form": "web page",
      "source_note": "",
      "source_sha256": "84e8874c4d143156d2772dbb1f7b5f1172bb07107de6778b77ea7b1a8499ded0",
      "source_text": "sources/laws/oh/oh-2025-hb96.txt",
      "source_url": "https://codes.ohio.gov/ohio-revised-code/section-3701.88",
      "state": "OH",
      "summary": "Each 340B covered entity sends the Ohio Department of Health a yearly report: what it paid for 340B drugs, what it was paid for them by payer type, what it paid contract pharmacies and others, how many contract pharmacies it uses, and an accounting of what it spent from 340B proceeds. The department posts the reports on its website.",
      "title": ""
    },
    {
      "act": "",
      "bill": "HB 2048",
      "binds": "Health insurers, pharmacy benefit managers and other third-party payers; drug manufacturers; 340B entities",
      "citation": "36 O.S. 5400 to 5405",
      "effective_date": "2025-11-01",
      "enforcement": "The Insurance Department, for insurers, and the Attorney General, for others, may fine $100 to $10,000 for each violation.",
      "kinds": [
        "contract-pharmacy",
        "payer-nondiscrimination",
        "other"
      ],
      "law_id": "ok-2025-hb2048",
      "limits": "The payer rules do not apply to Oklahoma Medicaid as payer. Became law after the legislature overrode the Governor's veto.",
      "more_sha256": "e572f661cbd8c9ed75d2ce25f05a63dbfe93a3e00a42e4f89d5df994ab56742e",
      "more_text": "sources/laws/ok/ok-2025-hb2048.more.txt",
      "more_url": "https://www.oklegislature.gov/BillInfo.aspx?Bill=HB2048&Session=2500",
      "quote": "A manufacturer shall not deny, restrict, prohibit, or otherwise interfere with, either directly or indirectly, the acquisition of a 340B drug by, or delivery of a 340B drug to a 340B entity, unless such receipt is prohibited by the United States Department of Health and Human Services",
      "retrieved": "2026-11-15",
      "session_year": "2025",
      "signed_date": "",
      "source_form": "pdf",
      "source_note": "",
      "source_sha256": "6bc462440b98571d3317da6418346d747d28a48f2d787781cbe46a44300f4aca",
      "source_text": "sources/laws/ok/ok-2025-hb2048.txt",
      "source_url": "https://www.oklegislature.gov/cf_pdf/2025-26%20ENR/hB/HB2048%20ENR.PDF",
      "state": "OK",
      "summary": "Insurers, pharmacy benefit managers and other payers may not pay a 340B entity less for 340B drugs, set different terms or fees, require a 340B modifier on a claim or keep it out of a network. A manufacturer may not interfere with a 340B drug reaching a 340B entity or its contract pharmacy. A 340B entity contracts with any willing pharmacy within fifteen miles on terms both accept.",
      "title": "340B Nondiscrimination Act"
    },
    {
      "act": "",
      "bill": "HB 2185",
      "binds": "Pharmacy benefit managers registered in Oregon",
      "citation": "ORS 735.530 and 735.534",
      "effective_date": "",
      "enforcement": "",
      "kinds": [
        "payer-nondiscrimination"
      ],
      "law_id": "or-2019-hb2185",
      "limits": "Applies to contracts entered into, renewed or extended on or after January 1, 2021. Does not apply to the state medical assistance program.",
      "more_sha256": "",
      "more_text": "",
      "more_url": "",
      "quote": "May not reimburse a 340B pharmacy differently than any other network pharmacy based on its status as a 340B pharmacy",
      "retrieved": "2026-11-15",
      "session_year": "2019",
      "signed_date": "",
      "source_form": "pdf",
      "source_note": "The enrolled copy prints no signing date and no chapter number.",
      "source_sha256": "31a44f883400a1df0c7c50cdf10b840b3fd14d50d9ec32955f95e258d4cda6bd",
      "source_text": "sources/laws/or/or-2019-hb2185.txt",
      "source_url": "https://olis.oregonlegislature.gov/liz/2019R1/Downloads/MeasureDocument/HB2185/Enrolled",
      "state": "OR",
      "summary": "A pharmacy benefit manager may not pay a 340B pharmacy differently from any other network pharmacy on the ground that it is a 340B pharmacy.",
      "title": ""
    },
    {
      "act": "Oregon Laws 2024, ch. 87",
      "bill": "HB 4149",
      "binds": "Pharmacy benefit managers; health insurers",
      "citation": "ORS 735.534 and 743A.062",
      "effective_date": "2024-04-04",
      "enforcement": "",
      "kinds": [
        "payer-nondiscrimination"
      ],
      "law_id": "or-2024-hb4149",
      "limits": "The 340B parts became operative January 1, 2025.",
      "more_sha256": "",
      "more_text": "",
      "more_url": "",
      "quote": "May not reimburse a 340B pharmacy differently than any other network pharmacy based on its status as a 340B pharmacy",
      "retrieved": "2026-11-15",
      "session_year": "2024",
      "signed_date": "2024-04-04",
      "source_form": "pdf",
      "source_note": "",
      "source_sha256": "11027fa8072e3a3b24aea784fe950009bcf0c137ba5f47d702eb556eda29299f",
      "source_text": "sources/laws/or/or-2024-hb4149.txt",
      "source_url": "https://www.oregonlegislature.gov/bills_laws/lawsstatutes/2024orLaw0087.pdf",
      "state": "OR",
      "summary": "A policy that pays for prescription drugs may not discriminate in paying for 340B drugs, charge fees or clawbacks for dispensing them, keep a pharmacy out of a network for dispensing them, or limit how or through how many pharmacies they are dispensed or delivered. A pharmacy benefit manager may not pay a 340B pharmacy differently from other network pharmacies.",
      "title": ""
    },
    {
      "act": "Oregon Laws 2025, ch. 297",
      "bill": "HB 2385",
      "binds": "Drug manufacturers and third parties that act for them",
      "citation": "",
      "effective_date": "",
      "enforcement": "The State Board of Pharmacy may set a civil penalty of up to $5,000 a day for each violation.",
      "kinds": [
        "contract-pharmacy"
      ],
      "law_id": "or-2025-hb2385",
      "limits": "Does not apply where the U.S. Department of Health and Human Services prohibits the acquisition, delivery or dispensing. Takes effect on the 91st day after the 2025 regular session adjourns.",
      "more_sha256": "01faff471ecd610c8dac07723d45a569f337e2f7fb2b506b2edac56e0ee1c186",
      "more_text": "sources/laws/or/or-2025-hb2385.more.txt",
      "more_url": "https://olis.oregonlegislature.gov/liz/2025R1/Measures/Overview/HB2385",
      "quote": "interfere directly or indirectly with the acquisi- tion of a 340B drug",
      "retrieved": "2026-11-15",
      "session_year": "2025",
      "signed_date": "",
      "source_form": "pdf",
      "source_note": "The saved pages print no calendar date for the start.",
      "source_sha256": "0f51f9a720c417cd6889d7f5a28c76b3470d0bc5417c63146949cd215aad3cee",
      "source_text": "sources/laws/or/or-2025-hb2385.txt",
      "source_url": "https://olis.oregonlegislature.gov/liz/2025R1/Downloads/MeasureDocument/HB2385/Enrolled",
      "state": "OR",
      "summary": "A manufacturer, or a third party acting for one, may not deny, restrict or otherwise interfere with a 340B drug reaching, or being dispensed by, a pharmacy in Oregon under contract with a covered entity, and may not require claim or utilization data as a condition.",
      "title": ""
    },
    {
      "act": "Oregon Laws 2025, ch. 346",
      "bill": "HB 3409",
      "binds": "Pharmacy benefit managers; health insurers",
      "citation": "ORS 735.530, 735.534 and 743A.062",
      "effective_date": "",
      "enforcement": "",
      "kinds": [
        "payer-nondiscrimination"
      ],
      "law_id": "or-2025-hb3409",
      "limits": "A pharmacy benefit manager does not have to join a clearinghouse. Takes effect on the 91st day after the 2025 regular session adjourns.",
      "more_sha256": "e55fd36251c683a1ccc025b0cf6437da0897eca27440acc7cf201521e1d6bdab",
      "more_text": "sources/laws/or/or-2025-hb3409.more.txt",
      "more_url": "https://olis.oregonlegislature.gov/liz/2025R1/Measures/Overview/HB3409",
      "quote": "May require a covered entity to submit a claim for reimbursement of a prescription drug that includes a modifier or other indicator that the drug is a 340B drug unless",
      "retrieved": "2026-11-15",
      "session_year": "2025",
      "signed_date": "",
      "source_form": "pdf",
      "source_note": "The saved pages print no calendar date for the start.",
      "source_sha256": "830ca2662e0606ac6885c8e9ff4c1282dd9822e1881aba10830821a0f2c3bebf",
      "source_text": "sources/laws/or/or-2025-hb3409.txt",
      "source_url": "https://olis.oregonlegislature.gov/liz/2025R1/Downloads/MeasureDocument/HB3409/Enrolled",
      "state": "OR",
      "summary": "A pharmacy benefit manager or insurer may require a 340B modifier on a claim, except where the covered entity has sent its 340B drug data to a clearinghouse of its own choosing that meets listed conditions. The sections keep the rules against paying a 340B pharmacy differently, charging it fees or keeping it out of a network.",
      "title": ""
    },
    {
      "act": "Act 77 of 2024",
      "bill": "HB 1993",
      "binds": "Pharmacy benefit managers registered with the Insurance Department",
      "citation": "Act of Nov. 21, 2016 (P.L. 1318, No. 169), section 601(a)(2)",
      "effective_date": "",
      "enforcement": "",
      "kinds": [
        "payer-nondiscrimination"
      ],
      "law_id": "pa-2024-hb1993",
      "limits": "One clause in an act on pharmacy benefit managers. The act writes the program's section as 340(b). Applies to contracts issued, renewed or amended after the clause took effect, 120 days after signing.",
      "more_sha256": "d24f083b7c4a0f69c97721156e2b1911db6240d2993bb63ace984c9aa84ae076",
      "more_text": "sources/laws/pa/pa-2024-hb1993.more.txt",
      "more_url": "https://www.palegis.us/legislation/bills/2023/hb1993",
      "quote": "Reimburse a federally qualified health center, health care facility or other entity participating in the program under section 340(b) of the Public Health Service Act (58 Stat. 682, 42 U.S.C. § 256(b)) an amount lesser than similar entities not participating in the program",
      "retrieved": "2026-11-15",
      "session_year": "2024",
      "signed_date": "2024-07-17",
      "source_form": "pdf",
      "source_note": "",
      "source_sha256": "8b4948b214a28896fcb824a265cdf2cab8ad7c7956969f950047330da5eee838",
      "source_text": "sources/laws/pa/pa-2024-hb1993.txt",
      "source_url": "https://www.legis.state.pa.us/WU01/LI/LI/US/PDF/2024/0/0077..PDF",
      "state": "PA",
      "summary": "A pharmacy benefit manager working for a health insurer may not pay a federally qualified health center or other entity in the 340B program less than it pays similar entities outside the program.",
      "title": ""
    },
    {
      "act": "P.L. 2025, ch. 288 and ch. 290",
      "bill": "S 0114 Substitute A; H 5634 Substitute A",
      "binds": "Health insurers, pharmacy benefit managers and other third-party payers; drug manufacturers; 340B covered entities",
      "citation": "R.I. Gen. Laws 5-19.3-1 to 5-19.3-9",
      "effective_date": "2025-10-01",
      "enforcement": "The Auditor General may investigate complaints and write rules. A breach is a deceptive trade practice or an unfair sales practice.",
      "kinds": [
        "contract-pharmacy",
        "payer-nondiscrimination",
        "reporting"
      ],
      "law_id": "ri-2025-s114",
      "limits": "Does not apply to Medicaid as payer. Limited distribution required by 21 U.S.C. 355-1 is allowed. Passed as two acts with the same text, both enacted June 27, 2025.",
      "more_sha256": "b9f51fc92ef9ad3d0276dd58cff289aa29ca6e087f61887b2c2f6cbdc333c032",
      "more_text": "sources/laws/ri/ri-2025-s114.more.txt",
      "more_url": "https://webserver.rilegislature.gov/PublicLaws/law25/law25290.htm",
      "quote": "Annually on or before April 1, each 340B covered entity participating in the federal 340B drug pricing program established by 42 U.S.C. § 256b shall submit to the office of the governor, the speaker of the house of representatives, the president of the senate, and auditor general a report detailing the 340B covered entity's participation in the program during the previous calendar year",
      "retrieved": "2026-11-15",
      "session_year": "2025",
      "signed_date": "",
      "source_form": "web page",
      "source_note": "",
      "source_sha256": "a72dbbf7fb568ac24b53a5d2bfc1b5a916f0610785025ab1d3f5c21a238a7a35",
      "source_text": "sources/laws/ri/ri-2025-s114.txt",
      "source_url": "https://webserver.rilegislature.gov/PublicLaws/law25/law25288.htm",
      "state": "RI",
      "summary": "Insurers, pharmacy benefit managers and other payers may not pay a 340B covered entity or contract pharmacy less, add fees or conditions, limit network participation or require a 340B marker on a claim. A manufacturer may not interfere with a 340B drug reaching a contract pharmacy. By April 1 each year a covered entity reports its 340B costs, payments, vendors and claims, and how it uses the savings.",
      "title": "Defending Affordable Prescription Drug Costs Act"
    },
    {
      "act": "SL 2019, ch. 213",
      "bill": "HB 1137",
      "binds": "Pharmacy benefit managers",
      "citation": "SDCL 58-29E-15",
      "effective_date": "",
      "enforcement": "",
      "kinds": [
        "payer-nondiscrimination"
      ],
      "law_id": "sd-2019-hb1137",
      "limits": "Rewritten in 2024 by a later act, also listed here.",
      "more_sha256": "59c2c300b0959ecd6fad48b0a636fe39834df2805152c51eb41cfc51e1848637",
      "more_text": "sources/laws/sd/sd-2019-hb1137.more.txt",
      "more_url": "https://sdlegislature.gov/api/Statutes/58-29E-15.html?all=true",
      "quote": "No pharmacy benefit manager may discriminate against a pharmacy participating in a health plan as an entity authorized to participate under section 340B of the Public Health Service Act, as amended to January 1, 2019, or any pharmacy under contract with such an entity to provide prescriptions",
      "retrieved": "2026-11-15",
      "session_year": "2019",
      "signed_date": "",
      "source_form": "pdf",
      "source_note": "The saved copy of the bill has blank approval lines; the code page prints the chapter of the act.",
      "source_sha256": "0359378c6f7a83bfcea45bcb986a17143dffa9b083cf8f8ad5b69ffc01997e8e",
      "source_text": "sources/laws/sd/sd-2019-hb1137.txt",
      "source_url": "https://mylrc.sdlegislature.gov/api/Documents/Bill/54265.pdf?Year=2019",
      "state": "SD",
      "summary": "A pharmacy benefit manager may not discriminate against a pharmacy in a health plan that is a 340B entity, or against a pharmacy under contract with one.",
      "title": ""
    },
    {
      "act": "SL 2024, ch. 203",
      "bill": "",
      "binds": "Pharmacy benefit managers and their affiliates",
      "citation": "SDCL 58-29E-15 and 58-29E-15.1",
      "effective_date": "2025-01-01",
      "enforcement": "A violator owes the 340B entity its actual and consequential damages, with attorneys' fees and costs.",
      "kinds": [
        "payer-nondiscrimination"
      ],
      "law_id": "sd-2024-ch203",
      "limits": "",
      "more_sha256": "",
      "more_text": "",
      "more_url": "",
      "quote": "Neither a pharmacy benefit manager nor a pharmacy benefit manager affiliate may, directly or indirectly, discriminate against a 340B entity or a pharmacy under contract with a 340B entity, on the basis that the 340B entity or a pharmacy under contract with a 340B entity participates in the 340B drug discount program by imposing terms or conditions that differ from a similarly situated entity that does not participate in the 340B drug discount program",
      "retrieved": "2026-11-15",
      "session_year": "2024",
      "signed_date": "",
      "source_form": "web page",
      "source_note": "The code pages print the chapter of the act, not its bill number.",
      "source_sha256": "59c2c300b0959ecd6fad48b0a636fe39834df2805152c51eb41cfc51e1848637",
      "source_text": "sources/laws/sd/sd-2024-ch203.txt",
      "source_url": "https://sdlegislature.gov/api/Statutes/58-29E-15.html?all=true",
      "state": "SD",
      "summary": "A pharmacy benefit manager or its affiliate may not discriminate against a 340B entity or its contract pharmacy: no lower payment, fees or chargebacks, network limits, required contracts, extra patient charges, limits on how drugs are dispensed or delivered, extra audits, or refusal to cover 340B drugs.",
      "title": ""
    },
    {
      "act": "SL 2025, ch. 198",
      "bill": "SB 154",
      "binds": "Drug manufacturers",
      "citation": "SDCL chapter 58-29G; 37-24-6",
      "effective_date": "",
      "enforcement": "A 340B entity or pharmacy may sue for an injunction, damages and attorneys' fees. A breach is also a deceptive act under section 37-24-6.",
      "kinds": [
        "contract-pharmacy"
      ],
      "law_id": "sd-2025-sb154",
      "limits": "Does not require a manufacturer to give a 340B price to a pharmacy. Limited distribution required by 21 U.S.C. 355-1 is allowed. Audits under federal law are allowed.",
      "more_sha256": "ea6bdda0cc339a4816746edfe4bed84fa79f9aebf3a8a75e21edc76b2b25d880",
      "more_text": "sources/laws/sd/sd-2025-sb154.more.txt",
      "more_url": "https://mylrc.sdlegislature.gov/api/Documents/284050.pdf",
      "quote": "A pharmaceutical manufacturer may not, directly or indirectly, deny, restrict, or prohibit the acquisition of a 340B drug or the delivery of a 340B drug to a location that is authorized to receive the drug by a 340B entity or pharmacy, unless receipt of the 340B drug is prohibited by federal law",
      "retrieved": "2026-11-15",
      "session_year": "2025",
      "signed_date": "",
      "source_form": "web page",
      "source_note": "The saved pages print no signing or effective date.",
      "source_sha256": "915e7c368de6f25eebdac68543afd788391cd7e5c93fc19eda1ef3d2c8cad645",
      "source_text": "sources/laws/sd/sd-2025-sb154.txt",
      "source_url": "https://sdlegislature.gov/api/Statutes/58-29G-2.html?all=true",
      "state": "SD",
      "summary": "A manufacturer may not deny, restrict or prohibit a 340B drug reaching a location that a 340B entity or pharmacy has authorized to receive it, and may not require claim or utilization data as a condition.",
      "title": ""
    },
    {
      "act": "Public Chapter 569 (2021)",
      "bill": "HB 1398",
      "binds": "Health insurers, pharmacy benefits managers and other third-party payers",
      "citation": "Tenn. Code Ann. Title 56, Chapter 7, Part 31 (new section)",
      "effective_date": "2021-07-01",
      "enforcement": "",
      "kinds": [
        "payer-nondiscrimination"
      ],
      "law_id": "tn-2021-hb1398",
      "limits": "Does not apply to TennCare, CoverKids or the state's prescription drug program.",
      "more_sha256": "",
      "more_text": "",
      "more_url": "",
      "quote": "Reimburse a 340B entity for pharmacy-dispensed drugs at a rate lower than the rate paid for the same drug by national drug code number to pharmacies that are not 340B entities",
      "retrieved": "2026-11-15",
      "session_year": "2021",
      "signed_date": "",
      "source_form": "pdf",
      "source_note": "",
      "source_sha256": "942f264d7033a723cd06486be263a12ffc04a69768f9f27fd8a092006cd50100",
      "source_text": "sources/laws/tn/tn-2021-hb1398.txt",
      "source_url": "https://publications.tnsosfiles.com/acts/112/pub/pc0569.pdf",
      "state": "TN",
      "summary": "An insurer, pharmacy benefits manager or other payer may not pay a 340B entity less for a drug than it pays other pharmacies, charge it a fee others do not pay, keep it out of a network on grounds not applied to others, or require a 340B modifier on a claim. It may not interfere with a patient's choice to get 340B drugs from a 340B entity.",
      "title": ""
    },
    {
      "act": "Public Chapter 404 (2025)",
      "bill": "SB 1414; HB 1242",
      "binds": "Drug manufacturers, their agents and affiliates; those that contract with a 340B entity to dispense its drugs or run its program",
      "citation": "Tenn. Code Ann. 47-18-136 and 47-18-104(b)",
      "effective_date": "",
      "enforcement": "A breach is an unfair or deceptive act with a civil penalty of $50,000 for each violation; each package of drugs counts once.",
      "kinds": [
        "contract-pharmacy"
      ],
      "law_id": "tn-2025-sb1414",
      "limits": "The manufacturer rules apply on or after July 1, 2025 and leave in place requirements that existed on or before June 1, 2025. Does not apply to TennCare, CoverKids or the state's prescription drug program.",
      "more_sha256": "6c741dfd9938e712070dd76723f2b4d43aa13a5c6f89ebda1c94591ac7cb7550",
      "more_text": "sources/laws/tn/tn-2025-sb1414.more.txt",
      "more_url": "https://wapp.capitol.tn.gov/apps/BillInfo/Default.aspx?BillNumber=SB1414&GA=114",
      "quote": "A drug manufacturer, or its agent or affiliate, shall not, either directly or indirectly, deny, impose any restrictions or prohibitions on, discriminate against, or otherwise limit the acquisition of a 340B drug by, or delivery of a 340B drug to, a 340B entity or other location that is under contract with, or otherwise authorized by, a 340B entity to receive 340B drugs on behalf of the 340B entity",
      "retrieved": "2026-11-15",
      "session_year": "2025",
      "signed_date": "2025-05-13",
      "source_form": "scanned pdf",
      "source_note": "The saved text was read from a scanned copy.",
      "source_sha256": "032cb3eb0d4d5322426c8a81dd844cd73c5e433aa7f509efbc39f93d248ca2eb",
      "source_text": "sources/laws/tn/tn-2025-sb1414.txt",
      "source_url": "https://publications.tnsosfiles.com/acts/114/pub/pc0404.pdf",
      "state": "TN",
      "summary": "A manufacturer may not set extra requirements on a 340B entity, such as data demands, claim reversals or audit and credentialing rules, or deny or limit a 340B drug reaching the entity or a location under contract with it. A contractor that dispenses 340B drugs or runs an entity's program may not restrict the entity's contracts or choices.",
      "title": ""
    },
    {
      "act": "Laws of Utah 2020, ch. 275",
      "bill": "SB 138",
      "binds": "Pharmacy benefit managers",
      "citation": "Utah Code 31A-46-102 and 31A-46-305",
      "effective_date": "2020-05-12",
      "enforcement": "",
      "kinds": [
        "payer-nondiscrimination"
      ],
      "law_id": "ut-2020-sb138",
      "limits": "Applies to contracts entered into or renewed on or after January 1, 2021. The payment and modifier rules do not cover drugs paid for by Medicaid.",
      "more_sha256": "ce8250420350fb45059f979a679400704e502ac97d8cf8841bb53060fe7de839",
      "more_text": "sources/laws/ut/ut-2020-sb138.more.txt",
      "more_url": "https://le.utah.gov/Session/2020/bills/static/SB0138.html",
      "quote": "require a claim for a drug to include a modifier to indicate that the drug is a 340B drug unless the claim is for payment, directly or indirectly, by the Medicaid program",
      "retrieved": "2026-11-15",
      "session_year": "2020",
      "signed_date": "2020-03-28",
      "source_form": "pdf",
      "source_note": "",
      "source_sha256": "e7e8dc28c645f7ee098fc79c358c8e13bd24c451c1b8c70df9b7d6379c1148ea",
      "source_text": "sources/laws/ut/ut-2020-sb138.txt",
      "source_url": "https://le.utah.gov/~2020/bills/sbillenr/SB0138.pdf",
      "state": "UT",
      "summary": "A pharmacy benefit manager may not pay a pharmacy a different amount for a drug on the ground that it is a 340B drug or the pharmacy is a 340B entity. It may not charge a 340B entity fees, restrict its network access, add patient charges or extra requirements for taking part in 340B, or require a 340B modifier on a claim.",
      "title": ""
    },
    {
      "act": "Laws of Utah 2021, ch. 317",
      "bill": "SB 140",
      "binds": "Health insurers",
      "citation": "Utah Code 31A-46-310",
      "effective_date": "2021-05-05",
      "enforcement": "",
      "kinds": [
        "payer-nondiscrimination"
      ],
      "law_id": "ut-2021-sb140",
      "limits": "Covers federally qualified health centers and their pharmacies only. Applies to contracts entered into or renewed on or after January 1, 2022. The payment and modifier rules do not cover drugs paid for by Medicaid.",
      "more_sha256": "601b75eafc5a7065791b12990e8b786c7e5f9fd248a70170e15b19ec603641ae",
      "more_text": "sources/laws/ut/ut-2021-sb140.more.txt",
      "more_url": "https://le.utah.gov/~2021/bills/static/SB0140.html",
      "quote": "require a claim for a drug to include a modifier to indicate that the drug is a 340B drug unless the claim is for payment",
      "retrieved": "2026-11-15",
      "session_year": "2021",
      "signed_date": "2021-03-17",
      "source_form": "pdf",
      "source_note": "",
      "source_sha256": "f483331c5a66419c4aab70cd82ca592fba327a3ffbff1acc8e090018e372848a",
      "source_text": "sources/laws/ut/ut-2021-sb140.txt",
      "source_url": "https://le.utah.gov/~2021/bills/sbillenr/SB0140.pdf",
      "state": "UT",
      "summary": "An insurer may not pay a federally qualified health center, or a pharmacy it runs or contracts with, a different amount for a drug on the ground of 340B status, and may not charge it fees, limit its network access or add patient charges or other requirements for taking part in 340B. An insurer may not require a 340B modifier on a claim.",
      "title": ""
    },
    {
      "act": "",
      "bill": "SB 69",
      "binds": "Drug manufacturers, their agents and affiliates",
      "citation": "Utah Code 31A-46-311",
      "effective_date": "2025-05-07",
      "enforcement": "",
      "kinds": [
        "contract-pharmacy"
      ],
      "law_id": "ut-2025-sb69",
      "limits": "Data that federal law requires is allowed, and delivery that federal law prohibits is not required. The state employee benefit program may adjust its practices to offset any cost.",
      "more_sha256": "38ff5e93bc432fb3c910e169d7f4c5c28a3c9246dd403a9c8d76d5ef9b220668",
      "more_text": "sources/laws/ut/ut-2025-sb69.more.txt",
      "more_url": "https://le.utah.gov/~2025/bills/static/SB0069.html",
      "quote": "the acquisition, dispensing, or delivery of a 340B drug to any location authorized by a 340B entity to receive the drug, unless prohibited by federal law",
      "retrieved": "2026-11-15",
      "session_year": "2025",
      "signed_date": "",
      "source_form": "pdf",
      "source_note": "",
      "source_sha256": "089632c925a76f4a02d63bd044c5ff486941b762374f91260ea91e75746b0eaf",
      "source_text": "sources/laws/ut/ut-2025-sb69.txt",
      "source_url": "https://le.utah.gov/Session/2025/bills/enrolled/SB0069.pdf",
      "state": "UT",
      "summary": "A manufacturer may not stop a pharmacy and a 340B entity from contracting, deny them a drug, block a 340B drug reaching a location the entity authorizes, limit the time to restock or to claim 340B pricing, or demand claim or utilization data as a condition of supply.",
      "title": ""
    },
    {
      "act": "",
      "bill": "HB 356",
      "binds": "Drug manufacturers, their agents and affiliates",
      "citation": "Utah Code 31A-46-311",
      "effective_date": "2026-05-06",
      "enforcement": "",
      "kinds": [
        "contract-pharmacy"
      ],
      "law_id": "ut-2026-hb356",
      "limits": "Amends the section added by the 2025 act, which is listed.",
      "more_sha256": "e03ceea21a0c1469d53c289641ee5084d973d46f282f7279adce2d887e813d57",
      "more_text": "sources/laws/ut/ut-2026-hb356.more.txt",
      "more_url": "https://le.utah.gov/~2026/bills/static/HB0356.html",
      "quote": "A manufacturer may not: (a) directly or indirectly restrict or prohibit: (i) a pharmacy from contracting with a 340B covered entity, including by denying the pharmacy access to a drug that is manufactured by the manufacturer",
      "retrieved": "2026-11-15",
      "session_year": "2026",
      "signed_date": "",
      "source_form": "pdf",
      "source_note": "",
      "source_sha256": "a99b32ac480a5df98a06ac020a2e40ef86a52a87215c921aa8e064d463a9d060",
      "source_text": "sources/laws/ut/ut-2026-hb356.txt",
      "source_url": "https://le.utah.gov/Session/2026/bills/enrolled/HB0356.pdf",
      "state": "UT",
      "summary": "Rewrites the section added in 2025: a manufacturer may not stop a pharmacy or 340B covered entity from contracting, limit 340B drugs reaching authorized locations, set time limits on restocking or claims, force a choice of supplier, demand claim or contract data as a condition, or interfere with pharmacy contracts.",
      "title": ""
    },
    {
      "act": "Acts 2022, ch. 319",
      "bill": "HB 1162",
      "binds": "Health insurers and pharmacy benefits managers",
      "citation": "Va. Code 38.2-3465 and 38.2-3467",
      "effective_date": "",
      "enforcement": "",
      "kinds": [
        "payer-nondiscrimination"
      ],
      "law_id": "va-2022-hb1162",
      "limits": "Hospitals are outside the act's meaning of covered entity. The first rule does not cover drugs that cost more than $250,000 a year for a patient. A later version of the section takes effect July 1, 2027.",
      "more_sha256": "b885846bb2caa41274df3b7e82cf6fe300095255b1a2186664c50063ed7bd87c",
      "more_text": "sources/laws/va/va-2022-hb1162.more.txt",
      "more_url": "https://law.lis.virginia.gov/vacode/title38.2/chapter34/section38.2-3467/",
      "quote": "Impose requirements, exclusions, reimbursement terms, or other conditions on a covered entity or contract pharmacy that differ from those applied to entities or pharmacies that are not covered entities or contract pharmacies on the basis that the entity or pharmacy is a covered entity or contract pharmacy or that the entity or pharmacy dispenses 340B-covered drugs",
      "retrieved": "2026-11-15",
      "session_year": "2022",
      "signed_date": "2022-04-11",
      "source_form": "web page",
      "source_note": "The saved pages print no effective date for the 2022 act.",
      "source_sha256": "26c79cf3b9ca4302f1eec8677505ef7f8a42d6c14b2e6f1a6893c6bfe99c0472",
      "source_text": "sources/laws/va/va-2022-hb1162.txt",
      "source_url": "https://legacylis.virginia.gov/cgi-bin/legp604.exe?221+ful+CHAP0319",
      "state": "VA",
      "summary": "An insurer, or a pharmacy benefits manager acting for it, may not set requirements, exclusions, payment terms or other conditions on a covered entity or contract pharmacy that differ from those for others on the ground that it is one or dispenses 340B drugs. It may not interfere with a person's choice of such a pharmacy.",
      "title": ""
    },
    {
      "act": "Acts 2026, ch. 887",
      "bill": "",
      "binds": "The Secretary of Health and Human Resources",
      "citation": "",
      "effective_date": "",
      "enforcement": "",
      "kinds": [
        "study"
      ],
      "law_id": "va-2026-ch887",
      "limits": "Sets no rule for manufacturers, insurers or clinics.",
      "more_sha256": "",
      "more_text": "",
      "more_url": "",
      "quote": "shall convene a stakeholder work group to conduct a comprehensive evaluation of the impacts of the federal 340B Drug Pricing Program within the Commonwealth",
      "retrieved": "2026-11-15",
      "session_year": "2026",
      "signed_date": "",
      "source_form": "web page",
      "source_note": "The saved page prints the chapter of the act, not its bill number, and no signing or effective date.",
      "source_sha256": "37bcbfed13a9c9dbad4b8918dfcc0ec5e6de87f818a26608785d5fadd10555ae",
      "source_text": "sources/laws/va/va-2026-ch887.txt",
      "source_url": "https://law.lis.virginia.gov/uncodifiedacts/2026/session1/chapter887/",
      "state": "VA",
      "summary": "The Secretary of Health and Human Resources convenes a work group to evaluate the effects of the 340B program in Virginia and reports to the chairs of named Senate and House committees by November 1, 2026.",
      "title": ""
    },
    {
      "act": "Act 131 of 2022",
      "bill": "H.353",
      "binds": "Pharmacy benefit managers and other third parties that pay for drugs",
      "citation": "18 V.S.A. chapter 221, subchapter 9 (section 9473)",
      "effective_date": "2023-01-01",
      "enforcement": "",
      "kinds": [
        "payer-nondiscrimination"
      ],
      "law_id": "vt-2022-h353",
      "limits": "Applies to contracts and plans issued or renewed on or after January 1, 2023. The modifier rule does not cover claims paid by Medicaid. Act 127 of 2024, which is listed, sets these rules in a new chapter and repeals this subchapter on July 1, 2029.",
      "more_sha256": "",
      "more_text": "",
      "more_url": "",
      "quote": "A pharmacy benefit manager or other third party that reimburses a 340B covered entity for drugs that are subject to an agreement under 42 U.S.C. § 256b through the 340B drug pricing program shall not reimburse the 340B covered entity for pharmacy-dispensed drugs at a rate lower than that paid for the same drug to pharmacies that are not 340B covered entities",
      "retrieved": "2026-11-15",
      "session_year": "2022",
      "signed_date": "2022-05-24",
      "source_form": "pdf",
      "source_note": "",
      "source_sha256": "7dc42b4f27e0a9b832616ae6f159c6563d35daebcfbe394232430855446dff2c",
      "source_text": "sources/laws/vt/vt-2022-h353.txt",
      "source_url": "https://legislature.vermont.gov/Documents/2022/Docs/ACTS/ACT131/ACT131%20As%20Enacted.pdf",
      "state": "VT",
      "summary": "A pharmacy benefit manager or other payer may not pay a 340B covered entity less than other pharmacies for the same drug, charge it fees or chargebacks for taking part in 340B, or discriminate against it in a way that interferes with a patient's choice. The act keeps an earlier rule against 340B claim modifiers and network limits tied to contract pharmacy arrangements until April 1, 2024.",
      "title": ""
    },
    {
      "act": "Act 127 of 2024",
      "bill": "H.233",
      "binds": "Pharmacy benefit managers and other third-party payers",
      "citation": "18 V.S.A. chapter 77, section 3631",
      "effective_date": "2024-07-01",
      "enforcement": "The Commissioner of Financial Regulation enforces the chapter and may set an administrative penalty.",
      "kinds": [
        "payer-nondiscrimination"
      ],
      "law_id": "vt-2024-h233",
      "limits": "Vermont Medicaid is not a third party under the section, and the modifier rule does not cover Medicaid claims. The contract rules apply to contracts issued, renewed or recredentialed on or after January 1, 2025.",
      "more_sha256": "",
      "more_text": "",
      "more_url": "",
      "quote": "A pharmacy benefit manager or other third party that reimburses a 340B covered entity for drugs that are subject to an agreement under 42 U.S.C. § 256b through the 340B drug pricing program shall not reimburse the 340B covered entity for pharmacy-dispensed drugs at a rate lower than that paid for the same drug to pharmacies that are not 340B covered entities",
      "retrieved": "2026-11-15",
      "session_year": "2024",
      "signed_date": "2024-05-30",
      "source_form": "pdf",
      "source_note": "",
      "source_sha256": "c79eb0c304c92efed1f0fbc4e794222d896a162bcd1b2f6089b1f4cdd0177d3d",
      "source_text": "sources/laws/vt/vt-2024-h233.txt",
      "source_url": "https://legislature.vermont.gov/Documents/2024/Docs/ACTS/ACT127/ACT127%20As%20Enacted.pdf",
      "state": "VT",
      "summary": "A pharmacy benefit manager or other payer may not pay a 340B covered entity less than other pharmacies or charge it fees for taking part in 340B, and may not interfere with a patient's choice of the entity. A pharmacy benefit manager may not require a 340B modifier on a claim, or limit network access or change payment on the ground of a contract pharmacy arrangement.",
      "title": ""
    },
    {
      "act": "Act 55 of 2025",
      "bill": "H.266",
      "binds": "Drug manufacturers and their agents; hospitals in the 340B program",
      "citation": "18 V.S.A. 4681 to 4685; 18 V.S.A. 9406",
      "effective_date": "",
      "enforcement": "A covered entity, contract pharmacy or other injured person may sue for an injunction, damages and attorney's fees; each package of drugs counts once.",
      "kinds": [
        "contract-pharmacy",
        "reporting"
      ],
      "law_id": "vt-2025-h266",
      "limits": "Does not apply to Vermont Medicaid as payer, or where the U.S. Department of Health and Human Services prohibits the delivery. Took effect on passage. The hospital report is repealed on January 1, 2031. As enacted the act also required a discount at purchase in place of a rebate; that paragraph was repealed in 2026.",
      "more_sha256": "c2ff3a9b3c75c313a7183bdb0d36e5ea36739f83dc47c1a6dab645a031390077",
      "more_text": "sources/laws/vt/vt-2025-h266.more.txt",
      "more_url": "https://legislature.vermont.gov/statutes/section/18/091/04682",
      "quote": "A manufacturer or its agent shall not deny, restrict, prohibit, or otherwise interfere with, directly or indirectly, the acquisition of a 340B drug by or delivery of a 340B drug to a 340B contract pharmacy on behalf of a 340B covered entity",
      "retrieved": "2026-11-15",
      "session_year": "2025",
      "signed_date": "2025-06-11",
      "source_form": "pdf",
      "source_note": "",
      "source_sha256": "9775e46fe1da7064541e6d284e1ca9065a07bf244275f321075308eb8f4e099c",
      "source_text": "sources/laws/vt/vt-2025-h266.txt",
      "source_url": "https://legislature.vermont.gov/Documents/2026/Docs/ACTS/ACT055/ACT055%20As%20Enacted.pdf",
      "state": "VT",
      "summary": "A manufacturer or its agent may not deny, restrict or interfere with a 340B drug reaching a covered entity's contract pharmacy, require claims or utilization data as a condition, or interfere with a contract pharmacy dispensing to eligible patients. Each hospital in the 340B program reports its 340B figures to the Green Mountain Care Board every January 31.",
      "title": ""
    },
    {
      "act": "Laws of 2026, ch. 227",
      "bill": "E2SSB 5981",
      "binds": "Drug manufacturers and third parties that act for them; federally qualified health centers and hospitals that are 340B covered entities",
      "citation": "Title 69 RCW (new chapter); chapter 43.71C RCW",
      "effective_date": "2026-06-11",
      "enforcement": "In a covered entity's suit a court may award a civil penalty of up to $5,000 a day for each violation. The Attorney General may enforce under the consumer protection act. A late report can be fined $1,000 a day after 30 days to correct it.",
      "kinds": [
        "contract-pharmacy",
        "reporting"
      ],
      "law_id": "wa-2026-sb5981",
      "limits": "The covered entity report applies to federally qualified health centers and to hospitals under 42 U.S.C. 256b(a)(4)(L) to (O). Their filing fees may cover no more than 25 percent of the authority's reporting costs.",
      "more_sha256": "3e691f58acfbd09d1345408a721dc702894e0c37bdb9a16b07dffa4eb1652a1d",
      "more_text": "sources/laws/wa/wa-2026-sb5981.more.txt",
      "more_url": "https://app.leg.wa.gov/billsummary?BillNumber=5981&Year=2025&Initiative=false",
      "quote": "A manufacturer or a third party acting on behalf of a manufacturer may not, directly or indirectly, deny, restrict, or prohibit the acquisition of a 340B drug by, or delivery of a 340B drug to, a covered entity",
      "retrieved": "2026-11-15",
      "session_year": "2026",
      "signed_date": "",
      "source_form": "pdf",
      "source_note": "",
      "source_sha256": "6d31ec8e7afebb050c5e4e04d0309c15a6d4c4113ad8267f3a502d8054ff7ddf",
      "source_text": "sources/laws/wa/wa-2026-sb5981.txt",
      "source_url": "https://lawfilesext.leg.wa.gov/biennium/2025-26/Pdf/Bills/Senate%20Passed%20Legislature/5981-S2.PL.pdf",
      "state": "WA",
      "summary": "A manufacturer, or a third party acting for one, may not deny, restrict or prohibit a 340B drug reaching a covered entity, a contract pharmacy or an authorized location, and may not require data as a condition. Federally qualified health centers and certain hospitals report their 340B figures, the use of savings included, to the Health Care Authority by April 1 each year; manufacturers report 340B units and discounts.",
      "title": ""
    },
    {
      "act": "Acts 2019, ch. 145",
      "bill": "SB 489",
      "binds": "Pharmacy benefit managers and other third-party payers, Medicaid managed care organizations included",
      "citation": "W. Va. Code 33-51-3 and 33-51-9",
      "effective_date": "2019-02-26",
      "enforcement": "",
      "kinds": [
        "payer-nondiscrimination"
      ],
      "law_id": "wv-2019-sb489",
      "limits": "Fee-for-service Medicaid is not a third party under the section; a Medicaid managed care organization is. Does not apply to claims under an ERISA employee benefit plan. The acts of 2021 and 2022 that amend the section are listed.",
      "more_sha256": "6bc64115856ab1db0b6845ff16aa446fb1b77e8c69a6b4e0efcd68a46e5cc66c",
      "more_text": "sources/laws/wv/wv-2019-sb489.more.txt",
      "more_url": "https://www.wvlegislature.gov/Bill_Status/bills_history.cfm?INPUT=489&year=2019&sessiontype=RS",
      "quote": "shall not reimburse the 340B entity for pharmacy-dispensed drugs at a rate lower than that paid for the same drug to pharmacies similar in prescription volume that are not 340B entities",
      "retrieved": "2026-11-15",
      "session_year": "2019",
      "signed_date": "2019-03-01",
      "source_form": "pdf",
      "source_note": "",
      "source_sha256": "ea00a37a9fa4a815a6189a57df0e4ec0078da3964c6e6da39a13dded6d070284",
      "source_text": "sources/laws/wv/wv-2019-sb489.txt",
      "source_url": "https://www.wvlegislature.gov/Bill_Text_HTML/2019_SESSIONS/RS/bills/SB489%20SUB1%20ENR.pdf",
      "state": "WV",
      "summary": "A pharmacy benefit manager or other third-party payer may not pay a 340B entity less than similar pharmacies outside the program, charge it fees or chargebacks for taking part, or interfere with a patient's choice to get 340B drugs from it.",
      "title": ""
    },
    {
      "act": "Acts 2021, ch. 164",
      "bill": "HB 2263",
      "binds": "Pharmacy benefit managers and other third parties that pay for 340B drugs",
      "citation": "W. Va. Code 33-51-3 and 33-51-9",
      "effective_date": "2021-06-28",
      "enforcement": "",
      "kinds": [
        "payer-nondiscrimination"
      ],
      "law_id": "wv-2021-hb2263",
      "limits": "Applies to policies and contracts delivered, amended or renewed on or after January 1, 2022. For the patient-choice rule, fee-for-service Medicaid is not a third party; Medicaid managed care plans are.",
      "more_sha256": "09fb33836be18e75d53fb774b824d78bc6a31c3c445f4e491242ca2999970cae",
      "more_text": "sources/laws/wv/wv-2021-hb2263.more.txt",
      "more_url": "https://www.wvlegislature.gov/Bill_Status/bills_history.cfm?INPUT=2263&year=2021&sessiontype=RS",
      "quote": "A pharmacy benefit manager, or any other third party, that reimburses a 340B entity for drugs that are subject to an agreement under 42 U.S.C. § 256b shall not reimburse the 340B entity for pharmacy-dispensed drugs at a rate lower than that paid for the same drug to pharmacies similar in prescription volume that are not 340B entities",
      "retrieved": "2026-11-15",
      "session_year": "2021",
      "signed_date": "2021-04-09",
      "source_form": "pdf",
      "source_note": "",
      "source_sha256": "c1ee0666fb6a17698c760f8f523cb46ce6b32ecdd604ce6196804401643ad46c",
      "source_text": "sources/laws/wv/wv-2021-hb2263.txt",
      "source_url": "https://www.wvlegislature.gov/Bill_Text_HTML/2021_SESSIONS/RS/bills/HB2263%20SUB%20ENR.pdf",
      "state": "WV",
      "summary": "A pharmacy benefit manager or other third party may not pay a 340B entity less than similar pharmacies, charge it fees or adjustments for taking part in 340B, interfere with a patient's choice to use it, or keep a pharmacy out of its network or cut its payment for dispensing 340B drugs.",
      "title": ""
    },
    {
      "act": "Acts 2022, ch. 159",
      "bill": "HB 4112",
      "binds": "Pharmacy benefit managers",
      "citation": "W. Va. Code 33-51-3, 33-51-9 and 33-51-13",
      "effective_date": "2022-06-10",
      "enforcement": "The Insurance Commissioner's rules set penalties, fines and loss of licence among them, for breaches of the article.",
      "kinds": [
        "payer-nondiscrimination"
      ],
      "law_id": "wv-2022-hb4112",
      "limits": "Applies to policies and contracts delivered or renewed on or after January 1, 2023. Medicaid may still prevent duplicate discounts, and the patient-choice rule does not cover fee-for-service Medicaid.",
      "more_sha256": "da48b578cee92075444c332ee65af46966aeb1d4193ba06fa5aa4cca72a41646",
      "more_text": "sources/laws/wv/wv-2022-hb4112.more.txt",
      "more_url": "https://www.wvlegislature.gov/Bill_Status/bills_history.cfm?INPUT=4112&year=2022&sessiontype=RS",
      "quote": "shall not reimburse the 340B entity for pharmacy- dispensed drugs at a rate lower than that paid for the same drug to pharmacies similar in prescription volume that are not 340B entities",
      "retrieved": "2026-11-15",
      "session_year": "2022",
      "signed_date": "2022-03-30",
      "source_form": "pdf",
      "source_note": "",
      "source_sha256": "eb5e1d4cafcc26a3d476c0691cdd188a7460c18f88b5af2019cfa408a56c3582",
      "source_text": "sources/laws/wv/wv-2022-hb4112.txt",
      "source_url": "https://www.wvlegislature.gov/Bill_Text_HTML/2022_SESSIONS/RS/bills/HB4112%20SUB%20ENR.pdf",
      "state": "WV",
      "summary": "A pharmacy benefit manager may not pay a 340B entity less than pharmacies of similar volume outside the program, or charge it fees, chargebacks or other adjustments; those include added requirements and a 340B modifier or resubmission on a claim. It may not discriminate against a 340B entity in a way that interferes with a patient's choice. The rule covers the state employee insurance agency.",
      "title": ""
    },
    {
      "act": "Acts 2024, ch. 93",
      "bill": "SB 325",
      "binds": "Drug manufacturers, their agents and affiliates",
      "citation": "W. Va. Code 60A-8-6a",
      "effective_date": "2024-06-06",
      "enforcement": "A civil penalty of $50,000 for each violation; each package of drugs counts once. The Board of Pharmacy may investigate complaints. There is no private right of action.",
      "kinds": [
        "contract-pharmacy"
      ],
      "law_id": "wv-2024-sb325",
      "limits": "Does not apply where the U.S. Department of Health and Human Services prohibits the delivery. Data that the department requires is allowed. Limited distribution required by 21 U.S.C. 355-1 is allowed.",
      "more_sha256": "7c41015667660e157b960b4b6bcd7e7519bde7026c3ec776a8e79b02b4ac38bb",
      "more_text": "sources/laws/wv/wv-2024-sb325.more.txt",
      "more_url": "https://www.wvlegislature.gov/Bill_Status/bills_history.cfm?INPUT=325&year=2024&sessiontype=RS",
      "quote": "A manufacturer, agent, or affiliate of such manufacturer shall not, either directly or indirectly, deny, restrict, or prohibit the acquisition of a 340B drug by, or delivery of a 340B drug to, a location authorized by a 340B entity to receive such 340B drug, unless the receipt of the 340B drug is prohibited by the United States Department of Health and Human Services",
      "retrieved": "2026-11-15",
      "session_year": "2024",
      "signed_date": "2024-03-27",
      "source_form": "web page",
      "source_note": "",
      "source_sha256": "eafce63dbc5fc87e24213af7c329359f68c90618c4685c8223f819619866ad05",
      "source_text": "sources/laws/wv/wv-2024-sb325.txt",
      "source_url": "https://code.wvlegislature.gov/60A-8-6a/",
      "state": "WV",
      "summary": "A manufacturer, its agent or affiliate may not deny, restrict or prohibit a 340B drug reaching a location that a 340B entity has authorized to receive it, and may not require claims or utilization data as a condition.",
      "title": ""
    }
  ],
  "license": "CC-BY-4.0",
  "not_listed": [
    {
      "name": "O.C.G.A. 33-64-9.1 (SB 313 and HB 946 of 2020)",
      "reason": "The official text of this section was not reached; the pages that were read did not show its 340B words.",
      "source_url": "",
      "state": "GA"
    },
    {
      "name": "HB 1001 of 2025 (state budget)",
      "reason": "The budget's text was not read.",
      "source_url": "",
      "state": "IN"
    },
    {
      "name": "SB 20 of 2026",
      "reason": "Names 340B only where it defines a rebate; it sets no rule about the program.",
      "source_url": "https://kslegislature.gov/li/b2025_26/measures/documents/sb20_enrolled.pdf",
      "state": "KS"
    },
    {
      "name": "SB 28 of 2024 (state budget)",
      "reason": "A budget condition for the fiscal years ending June 30, 2025 and June 30, 2026, which are over.",
      "source_url": "https://www.kslegislature.gov/li_2024/b2023_24/measures/documents/sb28_enrolled.pdf",
      "state": "KS"
    },
    {
      "name": "Minn. Stat. 62J.312, subdivision 6 (2023)",
      "reason": "Replaced in 2024 by Minn. Stat. 62J.461, which is listed.",
      "source_url": "",
      "state": "MN"
    },
    {
      "name": "Social Services Law 367-a (Medicaid pharmacy benefit)",
      "reason": "Came up in the search and has not been read yet.",
      "source_url": "",
      "state": "NY"
    },
    {
      "name": "Act 74 of 2021 (H.439), sections E.227.1 to E.227.3",
      "reason": "Its pharmacy benefit manager rule carried an end date and its report was due once, on January 15, 2022. Act 131 of 2022 and Act 127 of 2024, both listed, carry the rule now.",
      "source_url": "https://legislature.vermont.gov/Documents/2022/Docs/ACTS/ACT074/ACT074%20As%20Enacted.pdf",
      "state": "VT"
    },
    {
      "name": "ESSB 5187 of 2023 (state budget), section 211",
      "reason": "A budget condition tied to money for fiscal years 2024 and 2025, with one report due October 15, 2023.",
      "source_url": "https://lawfilesext.leg.wa.gov/biennium/2023-24/Pdf/Bills/Session%20Laws/Senate/5187-S.SL.pdf",
      "state": "WA"
    },
    {
      "name": "HB 5430 of 2026",
      "reason": "Re-enacts W. Va. Code 33-51-9 with the same 340B words as the 2022 act, which is listed.",
      "source_url": "https://www.wvlegislature.gov/Bill_Status/bills_history.cfm?INPUT=5430&year=2026&sessiontype=RS",
      "state": "WV"
    }
  ],
  "sites": [
    {
      "host": "arkleg.state.ar.us",
      "owner": "Arkansas General Assembly",
      "state": "AR"
    },
    {
      "host": "www.azleg.gov",
      "owner": "Arizona State Legislature",
      "state": "AZ"
    },
    {
      "host": "leginfo.legislature.ca.gov",
      "owner": "California Legislature",
      "state": "CA"
    },
    {
      "host": "vig.cdn.sos.ca.gov",
      "owner": "California Secretary of State",
      "state": "CA"
    },
    {
      "host": "leg.colorado.gov",
      "owner": "Colorado General Assembly",
      "state": "CO"
    },
    {
      "host": "www.cga.ct.gov",
      "owner": "Connecticut General Assembly",
      "state": "CT"
    },
    {
      "host": "delcode.delaware.gov",
      "owner": "State of Delaware, Delaware Code Online",
      "state": "DE"
    },
    {
      "host": "legis.delaware.gov",
      "owner": "Delaware General Assembly",
      "state": "DE"
    },
    {
      "host": "data.capitol.hawaii.gov",
      "owner": "Hawaii State Legislature",
      "state": "HI"
    },
    {
      "host": "www.legis.iowa.gov",
      "owner": "Iowa Legislature",
      "state": "IA"
    },
    {
      "host": "legislature.idaho.gov",
      "owner": "Idaho Legislature",
      "state": "ID"
    },
    {
      "host": "ilga.gov",
      "owner": "Illinois General Assembly",
      "state": "IL"
    },
    {
      "host": "my.ilga.gov",
      "owner": "Illinois General Assembly",
      "state": "IL"
    },
    {
      "host": "www.ilga.gov",
      "owner": "Illinois General Assembly",
      "state": "IL"
    },
    {
      "host": "iga.in.gov",
      "owner": "Indiana General Assembly",
      "state": "IN"
    },
    {
      "host": "kslegislature.gov",
      "owner": "Kansas Legislature",
      "state": "KS"
    },
    {
      "host": "www.kslegislature.gov",
      "owner": "Kansas Legislature",
      "state": "KS"
    },
    {
      "host": "apps.legislature.ky.gov",
      "owner": "Kentucky General Assembly",
      "state": "KY"
    },
    {
      "host": "legis.la.gov",
      "owner": "Louisiana State Legislature",
      "state": "LA"
    },
    {
      "host": "mgaleg.maryland.gov",
      "owner": "Maryland General Assembly",
      "state": "MD"
    },
    {
      "host": "legislature.maine.gov",
      "owner": "Maine Legislature",
      "state": "ME"
    },
    {
      "host": "lldc.mainelegislature.org",
      "owner": "Maine Legislature, Law and Legislative Reference Library",
      "state": "ME"
    },
    {
      "host": "www.mainelegislature.org",
      "owner": "Maine Legislature",
      "state": "ME"
    },
    {
      "host": "www.legislature.mi.gov",
      "owner": "Michigan Legislature",
      "state": "MI"
    },
    {
      "host": "www.revisor.mn.gov",
      "owner": "Minnesota Office of the Revisor of Statutes",
      "state": "MN"
    },
    {
      "host": "revisor.mo.gov",
      "owner": "Missouri Revisor of Statutes",
      "state": "MO"
    },
    {
      "host": "www.senate.mo.gov",
      "owner": "Missouri Senate",
      "state": "MO"
    },
    {
      "host": "billstatus.ls.state.ms.us",
      "owner": "Mississippi Legislature",
      "state": "MS"
    },
    {
      "host": "mca.legmt.gov",
      "owner": "Montana Legislature",
      "state": "MT"
    },
    {
      "host": "ncleg.gov",
      "owner": "North Carolina General Assembly",
      "state": "NC"
    },
    {
      "host": "www.ncleg.gov",
      "owner": "North Carolina General Assembly",
      "state": "NC"
    },
    {
      "host": "ndlegis.gov",
      "owner": "North Dakota Legislative Assembly",
      "state": "ND"
    },
    {
      "host": "governor.nebraska.gov",
      "owner": "Office of the Governor of Nebraska",
      "state": "NE"
    },
    {
      "host": "nebraskalegislature.gov",
      "owner": "Nebraska Legislature",
      "state": "NE"
    },
    {
      "host": "www.nebraskalegislature.gov",
      "owner": "Nebraska Legislature",
      "state": "NE"
    },
    {
      "host": "gc.nh.gov",
      "owner": "New Hampshire General Court",
      "state": "NH"
    },
    {
      "host": "nmlegis.gov",
      "owner": "New Mexico Legislature",
      "state": "NM"
    },
    {
      "host": "www.nmlegis.gov",
      "owner": "New Mexico Legislature",
      "state": "NM"
    },
    {
      "host": "www.leg.state.nv.us",
      "owner": "Nevada Legislature",
      "state": "NV"
    },
    {
      "host": "codes.ohio.gov",
      "owner": "Ohio Legislative Service Commission",
      "state": "OH"
    },
    {
      "host": "www.oklegislature.gov",
      "owner": "Oklahoma Legislature",
      "state": "OK"
    },
    {
      "host": "olis.oregonlegislature.gov",
      "owner": "Oregon State Legislature",
      "state": "OR"
    },
    {
      "host": "www.oregonlegislature.gov",
      "owner": "Oregon State Legislature",
      "state": "OR"
    },
    {
      "host": "www.legis.state.pa.us",
      "owner": "Pennsylvania General Assembly",
      "state": "PA"
    },
    {
      "host": "www.palegis.us",
      "owner": "Pennsylvania General Assembly",
      "state": "PA"
    },
    {
      "host": "webserver.rilegislature.gov",
      "owner": "Rhode Island General Assembly",
      "state": "RI"
    },
    {
      "host": "mylrc.sdlegislature.gov",
      "owner": "South Dakota Legislature",
      "state": "SD"
    },
    {
      "host": "sdlegislature.gov",
      "owner": "South Dakota Legislature",
      "state": "SD"
    },
    {
      "host": "publications.tnsosfiles.com",
      "owner": "Tennessee Secretary of State",
      "state": "TN"
    },
    {
      "host": "wapp.capitol.tn.gov",
      "owner": "Tennessee General Assembly",
      "state": "TN"
    },
    {
      "host": "le.utah.gov",
      "owner": "Utah State Legislature",
      "state": "UT"
    },
    {
      "host": "law.lis.virginia.gov",
      "owner": "Virginia General Assembly, Legislative Information System",
      "state": "VA"
    },
    {
      "host": "legacylis.virginia.gov",
      "owner": "Virginia General Assembly, Legislative Information System",
      "state": "VA"
    },
    {
      "host": "legislature.vermont.gov",
      "owner": "Vermont General Assembly",
      "state": "VT"
    },
    {
      "host": "app.leg.wa.gov",
      "owner": "Washington State Legislature",
      "state": "WA"
    },
    {
      "host": "lawfilesext.leg.wa.gov",
      "owner": "Washington State Legislature",
      "state": "WA"
    },
    {
      "host": "code.wvlegislature.gov",
      "owner": "West Virginia Legislature",
      "state": "WV"
    },
    {
      "host": "www.wvlegislature.gov",
      "owner": "West Virginia Legislature",
      "state": "WV"
    }
  ]
}
